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A PLATFORM FOR THE DISCOVERY AND CHACTERIZATION OF PROTEINS THAT 
ASSOCIATE WITH PSEUDOMONAS AERUGINOSA RNA POLYMERASE 
By 
Danielle N. Brogren  
Pseudomonas aeruginosa is an opportunistic bacterial pathogen notable for its ability to 
colonize the lungs of cystic fibrosis patients. Once the bacterium infects and colonizes humans, it 
is extremely difficult to eradicate. This leads to long-term infections that significantly damage 
the lungs and other tissues. P. aeruginosa infections are challenging to treat due to the 
bacterium’s natural antibiotic resistance and the rise of multidrug resistant strains. Development 
of novel drug treatments are a necessity.  
In all organisms, the regulation of gene expression is a highly controlled process. 
Remarkably, in P. aeruginosa bioinformatics studies showed that 20% of its genome is dedicated 
to regulating transcription, the first stage of gene expression. However, the vast majority of 
proteins that regulate transcription in P. aeruginosa are poorly understood. Understanding gene 
regulation is a promising strategy for discovery of novel drug targets. RNA polymerase (RNAP) 
is an essential enzyme controlling gene regulation, and its activity is modulated through a 
plethora of transcription factors or other proteins. The regulation of gene expression has been 
best studied in E. coli.  
The aim of this work was to develop a platform to study RNAP-interacting proteins in P. 
aeruginosa. To do this, we took advantage of an E. coli RNAP “coreome” library. The RNAP 
“coreome” was a term developed to describe 38 different plasmids each expressing surface 
exposed regions of RNAP inputted into a bacterial two-hybrid assay. In general, RNAP is a 
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highly conserved enzyme among bacteria. Alignments of the amino acids of each piece of the E. 
coli RNAP coreome to specific domains of P. aeruginosa RNAP have shown a high degree of 
similarity (between 82-100%). The coreome was constructed based on the high-resolution 
structure of the bacteria Thermus aquaticus RNAP suggesting that E. coli β RNAP can be parsed 
into 10 sub-domains. Analysis of the E. coli β’ subunit of RNAP suggested that it could be 
parsed into 18 sub-domains that cover the entire gene (Nickels, 2009).  
 A bacterial two-hybrid assay can be utilized to determine if a specific target protein 
interacts with domains of RNAP found within the RNAP coreome. Data from the IntAct 
Molecular Interaction Database identified 147 E. coli proteins that directly or indirectly interact 
with RNAP. We performed a bioinformatic analyses to identify P. aeruginosa homologs to these 
E. coli proteins. Initially, sixteen P. aeruginosa proteins were screened against the E. coli RNAP 
coreome in the bacterial two-hybrid assay. 
In this work five P. aeruginosa proteins, AlgQ, NusG, ClpA, DppF, and Tig were shown 
to interact with particular fragments of the E. coli RNAP coreome. Specifically, we show that 
AlgQ interacted with σ 528-613, NusG interacted with β’249-328 and β’264-308, ClpA 
interacted with β 829-930 and β 831-1059, DppF interacted with β' 114-190 and β 1137-1226, 
and Tig interacted with β' 735-790 and β 450-530. These results indicate the E. coli RNAP 
coreome can be utilized to uncover RNAP-interacting proteins in P. aeruginosa and to discover 
the precise domains they contact. In the future if the RNAP-binding determinants or proteins that 
control expression of virulence factors are identified using the RNAP coreome, it may be 
possible to design novel drugs that either disrupt the function of those proteins or their 
interaction with RNAP. Ultimately, this could lead to improved treatment options for P. 
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Pseudomonas aeruginosa is a metabolically versatile bacteria, which can be 
found in numerous niches including soil, marine habitats, and on animal and plant tissues 
(Stover et al., 2000). Being an opportunistic pathogen, P. aeruginosa generally poses no 
threat when it comes into contact with an immunocompetent human host (Lang et al., 
2004). However, immune compromised individuals, such as cancer patients, burn 
victims, and patients with cystic fibrosis (CF) are more susceptible to infection with this 
pathogen (Hirsch & Tam, 2010).  
 P. aeruginosa is naturally resistant to a number of antibiotics because it contains 
membrane proteins that transport toxic substances out of the cell. Multidrug efflux 
systems (MES) such as the MexAB-OprM are efficient membrane pumps that allow the 
natural resistance to a number of antibacterial agents including β-lactams, β-lactamase 
inhibitors, quinolones, chloramphenicol and tetracycline (Aires et al., 1999). Apart from 
antibacterial agents, the Mex efflux system of P. aeruginosa can also cause resistance to 
a number of organic solvents, biocides, dyes, and cell signaling molecules (Papadopoulos 
et al., 2008).  
P. aeruginosa also possesses numerous virulence factors that allows it to 
successfully colonize diverse regions of its host. Such virulence factors include adhesions 
that are responsible for binding to epithelial cells and exotoxins that disrupt immune 
clearance mechanisms (Tang et al., 1996). The number of carbapenem resistant P. 
aeruginosa infections has also been on the rise. These are especially dangerous since 
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carbapenem is often the antibiotic of last resort to treat P. aeruginosa infections 
(Livermore, 2002). All of these factors contributes to the difficulty of treating P. 
aeruginosa infections, making it necessary to develop novel treatments (Stover et al., 
2000).  
  One of the groups most vulnerable to P. aeruginosa infections are patients with 
CF. At age 20, up to 80% of CF patients suffer from chronic lung infection with P. 
aeruginosa (Lang et al., 2004). The immune system is not successful at eradicating the 
infection and causes massive inflammation leading to the destruction of lung tissue and 
ultimately lung function (Emerson et al., 2002;Lang et al., 2004). In burn patients, a 77% 
mortality rate was seen with P. aeruginosa infections (Lyczak et al., 2000). Development 
of antibiotic resistance in P. aeruginosa in these vulnerable patient populations is also 
problematic. Other therapies are required to treat this pathogen, and one area of research 
that may be promising focuses on disrupting transcription factor (TF) function/RNAP-
interacting proteins.  
In all organisms, transcription, and regulation of gene expression is a highly 
regulated process. Remarkably, P. aeruginosa bioinformatics studies showed that 20% of 
its genome is dedicated to regulating transcription, approximately 1,200 proteins (Stover 
et al., 2000). In comparison, E. coli has only 10% of its genome dedicated to regulating 
transcription (Blattner et al., 1997). Regulation of transcription can occur by modulating 
the activity of RNA polymerase (RNAP), often through the action of TFs. A better 
understanding of gene regulation in P. aeruginosa, specifically through the role of TFs, 
could lead to the discovery of new targets for antibiotic design.   
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The objective of this study is to identify potential TFs and other RNAP-
interacting proteins or other proteins that interact with RNAP. In E. coli, 147 proteins 
were shown to either directly or indirectly interact with RNAP (see Table 1). Because E. 
coli and P. aeruginosa are in the same class of bacteria, gammaproteobacteria, it is likely 
that these E. coli RNAP-interacting proteins could be functioning as RNAP-interacting 
proteins in P. aeruginosa. 
 Compared to E. coli, much less is known about transcriptional regulation in P. 
aeruginosa. By utilizing the protein-protein interaction database (IntAct Molecular 
Interaction Database-www.ebi.ac.uk/intact), a list of E. coli RNAP-interacting proteins 
was obtained. From here, bioinformatic analysis was performed to identify specific 
homologs to these E. coli proteins in P. aeruginosa. Using this approach, sixteen P. 
aeruginosa homologs were selected for further analysis in the bacterial two-hybrid assay 
based on the following criteria: (1) The P. aeruginosa proteins must have been greater 
than 70% identical to its E. coli counterpart, and (2) They must have had no previously 
described interactions with RNAP in P. aeruginosa. As controls, two P. aeruginosa 
proteins were chosen that had previously described interactions with RNAP. These were 













Table 1. List of E. coli proteins that were shown to be associated with binding 
directly or indirectly to RNAP. The proteins highlighted in yellow are the initial 
putative TFs that have significant similarity in P. aeruginosa and will be utilized in 
the bacterial two-hybrid assay. ♥= genes that have been cloned into the pBRα 
expression vector. Shaded boxes indicate TFs with literature evidence implicating 
a particular binding site domain on RNAP. One of these proteins (NusG) will be 
used as a control. (IntAct Molecular Interaction Database-www.ebi.ac.uk/intact). 



























Pseudomonas aeruginosa is a versatile Gram-negative bacterium that is found in 
soil, marine habitats, and on plant and animal tissues. The emergence of P. aeruginosa as 
an opportunist pathogen is due to its increasing resistance to antibiotics and disinfectants 
(Stover et al., 2000). P. aeruginosa is known to form biofilms on various surfaces, where 
these biofilms are important for its colonization and persistence in many patients, such as 
burn victims, patients that have implanted medical devices such as catheters and 
respirators, patients that have urinary tract infections (UTI) and hospital-acquired 
pneumonia (Sadikot et al., 2005).  
The ubiquitous nature of P. aeruginosa is due to its ability to utilize diverse 
sources of carbon and other nutrients (Stover et al., 2000). With a genome of 6.3 million 
base pairs (Mbp), which is about 50% bigger than average bacteria, a larger number of 
open reading frames (ORFs), and 20% of its genome dedicated to gene regulation, P. 
aeruginosa is metabolically versatile. This metabolic versatility allows P. aeruginosa to 
thrive in diverse hosts and environments. There are many potential sources of nutrients P. 
aeruginosa encounters in these different environments and its ability to adjust its 
metabolism accordingly is crucial for its survival (Stover et al., 2000).  
 P. aeruginosa is most notable for lung colonization of cystic fibrosis (CF) 
patients, contributing to severe morbidity and mortality. Once colonization occurs, P. 
aeruginosa is almost impossible to eradicate due to its natural resistance to antibiotics, 
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leading to pulmonary failure and death (Stover et al., 2000). About 30% of CF infants can 
obtain strains of P. aeruginosa from the environment, triggering acute infection. By the 
age of 3, the rate of infection increases to nearly 50%. Some individuals end up acquiring 
mucoid phenotypes leading to chronic infections (Moradali et al., 2017). Cystic fibrosis 
patients suffering from chronic lung infections are exposed to an overproduction of 
alginate, an exopolysaccharide. This overproduction contributes to the persistence of the 
bacterium in the CF lung (Suh et al., 1999). P. aeruginosa ability to quickly adapt and 
persist in the CF lung causes a 70% mortality rate in adults (Moradali et al., 2017).  
Additionally, P. aeruginosa is largely implicated in hospital-acquired infections 
including ventilator-associated pneumonia, UTI’s, surgically implanted devices and 
central line-associated bloodstream infections (Hirsch & Tam, 2010; Moradali et al., 
2017). From 1986-2003, the National Nosocomial Infections Surveillance reported that 
P. aeruginosa was the second most common cause of pneumonia (18.1%), the third most 
common UTI (16.3%), and the eight most common pathogen isolated from the blood 
stream (3.4%) (Hirsch & Tam, 2010). The prevalence of P. aeruginosa in healthcare 
settings is common because of its ability to live on abiotic and biotic surfaces such as 
medical devices while being resistant to various disinfectants and enabling frequent 
transmission from patient-to-patient (Moradali et al., 2017).  
P. aeruginosa infections are challenging to treat with antibiotics due to the 
bacterium’s natural resistance and the rise of multidrug resistant strains worldwide. 
Resistance to common antibiotic classes include carbapenems, cephalosporins, 
fluoroquinolones and aminoglycosides (Moradali et al., 2017). Biofilm formation in P. 
aeruginosa is a highly regulated process. These cells respond to various external signals 
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including the nutrients in the environment, or lack thereof (O’Toole & Kolter, 1998). 
Biofilms allow for the adherence to diverse surface types. This capacity to form biofilms 
impacts human health. It aids in P. aeruginosa’s ability to colonize medical devices, 
often leading to chronic infections. Other benefits afforded by the biofilm include 
protection from host defenses and resistance to antibiotics and disinfectants (López et al., 
2010; O’Toole & Kolter, 1998).  
The reduced permeability of the P. aeruginosa outer membrane, coupled with 
multiple multidrug efflux systems (MES) account for the mechanisms that underlie its 
natural resistance to antibiotics and disinfectants. Many of the P. aeruginosa MES 
proteins are in the resistance-nodulation-cell division (RND) family that allows the efflux 
of antimicrobial substrates P. aeruginosa has twelve RND efflux systems, and of these 
four RND pumps contribute significantly to antibiotic resistance: MexAB-OprM, 
MexCD-OprJ, MexEF-OprN, and MexXY-OprM (Dreier & Ruggerone, 2015).  
Overexpression of these four systems can result in broad antimicrobial resistance 
causing multidrug resistance (Hirsch & Tam, 2010). Each RND pump transports out or 
accepts specific antibacterial agents. MexB transports β-lactams. MexD recognizes 
fluoroquinolones, zwitterionic cephalosporins, macrolides, chloramphenicol, 
trimethoprim, and tetracyclines. MexF accepts fluoroquinolones, chloramphenicol, 
trimethoprim, and tetracycline as substrates. MexY transports aminoglycosides, 
fluoroquinolones, macrolides, tetracyclines, tigecycline, and zwitterionic cephalosporins 
(Dreier & Ruggerone, 2015).  
Multidrug resistant P. aeruginosa is resistant to virtually all classes of antibiotics. 
Carbapenems are typically the drug of last resort to treat P. aeruginosa infections. With 
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the rise of carbapenem-resistant P. aeruginosa infections, other treatment methods are a 
high research priority (Dreier & Ruggerone, 2015). The World Health Organization 
(WHO) generated a list of bacteria for which new antibiotics are urgently needed in 
February 2017. Second on the priority list was carbapenem-resistant P. aeruginosa. 
http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/  
In addition to being naturally resistant to many antibiotics, P. aeruginosa has 
numerous virulence factors that contribute to this pathogen’s success. Virulence factors in 
this organism range from toxins delivered through protein secretion pathways (i.e. type 1, 
2 and 3 secretion systems) to biofilm formation on lung epithelial cells or surgical 
implants. P. aeruginosa also consist of two quorum sensing (QS) systems; the LasR–LasI 
and the RhlR–RhlI, with the cognate signal molecules N‐(3‐oxo‐dodecanoyl)‐l‐
homoserine lactone (OdDHL) and N‐buturyl‐l‐homoserine lactone (BHL). Both systems 
induce production of key virulence factors such as exoproteases, siderophores, exotoxins 
and several secondary metabolites (Hentzer et al., 2003). Targeting these mechanisms 
and specific proteins that are crucial for P. aeruginosa survival and understanding what 
regulates the expression of these genes could lead to novel drug therapies (Stover et al., 
2000).  
A large number of P. aeruginosa genes are involved in transcription regulation 
(Stover et al., 2000). Our understanding of transcription factors (TFs) and other proteins 
that interact with RNA polymerase (RNAP) in P. aeruginosa is very limited. A bacterial 
two-hybrid assay will allow us to dissect protein-protein interactions with RNAP. This 
work will contribute to a better understanding of how TFs and other proteins interact with 
RNAP in P. aeruginosa.  
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RNAP is an enzyme that is essential for all life. RNAP initiates and regulates the 
expression of genes by transcribing a DNA sequence into mRNA (Yuan et al., 2008). TFs 
are proteins that can interact with RNAP to modulate its activity by either activating or 
repressing gene expression. Transcription factors and other RNAP-interacting proteins 
therefore play an essential role in the process of gene regulation by controlling which 
genes can be turned on or off by RNAP. A bacterial two-hybrid assay was developed in 
order to gain a better understanding of protein-protein interaction within cells. 
 
Bacterial Two-Hybrid Assay 
A transcription activation-based bacterial two-hybrid assay was developed by 
Dove et al. (1997) to gain a better understanding of protein-protein interaction within 
cells. This has been an effective tool to studying protein interactions from any organism 
within E. coli. The assay has been used extensively to study direct interaction with 
proteins with the various structural domains of RNAP.  
 In this assay a sufficiently strong interaction between any two proteins can 
activate transcription of a reporter gene if one of the interacting proteins is fused to the 
DNA-binding domain of the bacteriophage λcI protein, and the other protein of interest is 
fused to the α-subunit NTD of E. coli RNAP (Dove & Hochschild, 2004). Thus, the 
genes encoding the proteins of interest are expressed from two different plasmids, 
designated as either the “bait” or “prey” plasmid.  The bait protein is fused to the λcI 
protein. The prey plasmid expresses the other protein under study fused to the NTD of E. 
coli RNAP. The strength of the protein-protein interaction between the two proteins 
defines the amount of reporter gene activation (Dove and Hochschild, 2004). Figure 1 




Figure 1: Basic structure of a bacterial two-hybrid assay. Y is the bait protein fused to λcI 
and X is the prey protein fused to the α-subunit unit of RNAP. If there is a strong 
interaction between X and Y the reporter gene will be expressed. αNTD is the alpha 
subunit of RNAP. -35 and -10 are the promoter regions. lacZ encodes β-galactosidase. 
 
Use of the two-hybrid assay to study regulatory proteins for known interactions 
with RNAP 
 
A vital step in the analysis of TF function is to determine whether the regulatory 
factor makes direct contact with RNAP. However, determining whether a protein makes 
direct contact with RNAP and identifying specifically where it binds on the enzyme can 
be challenging (Nickels, 2009). The bacterial two-hybrid assay can be used for various 
applications that allow dissection of any protein-protein interactions, including those 
involved in gene regulatory circuits. Here are a few examples of the utilization of the 
bacterial two-hybrid assay to show protein-protein interaction.  
E. coli Rsd protein has been suggested to function as a σ70-specific anti σ factor 
first identified by Jishage and Ishihama in 1998. Rsd is produced at the onset of 
stationary phase of growth and is found in a complex with σ70  in stationary cell extracts 
(Yuan et al., 2008). Biochemical analysis was performed and Rsd was shown to associate 
specifically with σ70, inhibiting transcription from certain σ70-dependent promoters in 
reactions containing purified Rsd and purified RNAP holoenzyme (Yuan et al., 2008).  
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P. aeruginosa encodes a transcriptional regulator known as AlgQ. This protein 
has a 55% amino acid sequence similarity with E. coli Rsd. AlgQ regulates the 
production of several virulence factors in P. aeruginosa, one of particular interest is 
alginate. The primary sigma factors share four regions of conserved sequences (regions 
1-4). Regions 2 and 4 have DNA-binding domains that recognize the conserved elements 
-10 and -35 elements of σ70– dependent promoters, respectively region 2 also interacts 
with the coiled domain of the β’ subunit that is critical for holoenzyme formation. Region 
4 also interacts with the β subunit flap domain (β-flap). This interactions positions the 
region 4 in contact with the promoter -35 element when region 2 is bound to a -10 
element (Yuan et al., 2008).  
Several studies suggested that Rsd binds with σ70 region 4. A high-resolution 
crystal structure reveals that Rsd affects the binding of σ70 to both the -35 element and the 
β-flap. To investigate further the function of Rsd, mutants were constructed and a genetic 
screen was used to identify mutants that act as potential inhibitors of σ70–dependent 
transcription than wild-type Rsd (Yuan et al., 2008). 
 Because previously described interaction of Rsd with σ70 region 4 were already 
known, Rsd substitutions were tested using a bacterial two-hybrid assay. σ70 interactions 
with region 2 was also tested. A bacterial two-hybrid assay adapted and then used to 
detect bridging interactions between Rsd and AlgQ. These serve as protein bridges to link 
two fused protein domains (σ70 region 2 and σ70 region 4) that do not interact directly 
(Yuan et al., 2008). 
It was found that both Rsd and AlgQ interact simultaneously with regions 2 and 4 
of σ70 (Figure 2), indicating that they both have the possibility to form interfaces with 
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full-length σ70. AlgQ, originally identified for the production of alginate, was found to 
influence expression of multiple virulence factors including pyocyanin. With the use of 
the bacterial two-hybrid assay this allowed further investigation of interactions of the 
proteins of interest (AlgQ and Rsd) with RNAP.  
 
Figure 2: A bacterial two-hybrid assay used to detect protein–protein interactions 
between Rsd and σ70. Rsd interacts with σ70 region 2. Rsd, indicated as Y fused to the 
bacteriophage λcI protein, and σ70 region 4 indicated as X fused to the α-N-terminal 
domain (α-NTD). The interaction between X and Y activates transcription from the test 
promoter and drives the expression of lacZ. -35 and -10 are the promoter regions. lacZ 
encodes β-galactosidase. 
 
Use of the two-hybrid assay to study regulatory proteins of unknown interactors 
Chlamydia trachomatis, an intracellular human pathogen, undergoes 
developmental programs between two forms: the infectious elementary body (EB), and 
the rapidly dividing reticulate body (RB). However, regulators of this developmental 
process are not known. To identify potential regulators of transcription in C. trachomatis, 
a genomic library for sequences encoding proteins interacting with RNAP were screened. 
It was found that CT663 interacts with the β and σ subunits of RNAP (Rao et al., 2009). 
The bacterial two-hybrid assay was used to characterize the protein interaction of CT663 
with the β-flap domain (bait plasmid) of C. trachomatis of RNAP (Rao et al., 2009).   
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A bacterial two-hybrid was then used to dissect specific amino acid residues in 
the β-flap that mediated the CT663/β–flap interaction. Figure 3 depicts the bacterial two-
hybrid assay used to screen the C. trachomatis protein library against the β-flap domain 
of RNAP. This screen identified 4 candidate plasmids that encoded in-frame fusion 
proteins. One plasmid pBRL28, corresponds to the position of 760498-761436 of the C. 
trachomatis of serovar D genome (GenBank ID: NC_000117) that encodes CT663 and 
CT664, both of which encode proteins of unknown functions. Protein BLAST analysis 
was performed and identified CT633 as a type III chaperone in enteropathogenic E. coli. 
CT664 was identified as a member of the fork-head-associated domain family. 
With the use of the bacterial two-hybrid assay, isolation and characterization of 
CT663 was identified (Figure 3). Originally, studying gene regulation in C. trachomatis 
was rather difficult due to the lack of a tractable genetic system for this organism. With 
further studies CT663 was found to inhibit transcription in vitro by RNAP with either 











Figure 3: CT663 interaction with β-flap of RNAP. A bacterial two-hybrid assay was 
utilized to screen C. trachomatis DNA library for proteins that could potentially interact 
with β-flap domain of RNAP. β-flap fused to the bacteriophage λcI protein, and C. 
trachomatis DNA library fused to the α-N-terminal domain (αNTD). The interaction 
between C. trachomatis DNA library and β-flap domain of RNAP activates transcription 
from the test promoter and drives the expression of lacZ. -35 and -10 are the promoter 
regions. lacZ encodes β-galactosidase. 
 
Use of the two-hybrid assay to study a phage encoded inhibitor of RNA synthesis 
Phage G1 gp67 was identified as an inhibitor of cell growth and RNA synthesis 
when expressed in Staphylococcus aureus. Gp67 was found to interact directly with 
region 4 of the primary σ factor in S. aureus, σA  (Montero-Diez et al., 2013). Previous 
studies indicated that gp67 inhibits transcription from the rRNA promoters but is not 
influencing transcription from cellular promoters (Montero-Diez et al., 2013).  
The use of an E. coli RNAP components to analyze gp67 was not feasible because 
there are no interactions between gp67 and E. coli σ70. However, amino acid substitutions 
in σ70 region 4 were introduced that enabled an interaction with gp67 (Montero-Diez et 
al., 2013). This amino acid substitution was selected due to some sequence divergence 
between Gram-positive and Gram-negative bacteria (Montero-Diez et al., 2013)  . 
An E. coli-based transcription system was then used to study transcription from 
identical rRNA promoters that either contain or do not contain the UP element. The UP 
element is a component of bacterial promoters located upstream of the −35 hexamer, 
increases transcription by interacting with the RNA polymerase α-subunit. The bacterial 
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two-hybrid assay identified the strong inhibitory effect of gp67 on rrnB P1 transcription 
and the independence of the UP element and αCTD as depicted in Figure 4. 
 
Figure 4: Bacterial two-hybrid assay used to dissect the gp67-σ4 interaction. The diagram 
shows how the interaction between σ4 fused to the RNAP α-N terminal domain (NTD) 
and gp67 or β-flap fused to the bacteriophage λcI protein activates the transcription of a 
lacZ reporter gene. -35 and -10 are the promoter regions. lacZ encodes β-galactosidase. 
 
Use of the two-hybrid assay to study the interaction between AsiA and RNAP 
Bacteriophage T4 AsiA makes direct contact with the β-flap domain of RNAP.  
This protein inhibits transcription at E. coli σ70– dependent promoters. Prior research has 
established AsiA-dependent transcription inhibition depends on an interaction with 
region 4 of σ70. A bacterial two-hybrid assay was used to demonstrate the interaction 
between AsiA and β-flap of RNAP and that it interacts simultaneously with β-flap and 
region 4 of σ70 as depicted in Figure 5 (Yuan et al, 2009).  
Because β-flap and region 4 of σ70 interact directly without bridging proteins, 
previously characterized amino acid substitutions in σ70 region (L607P) that disrupt σ70 
region 4/β-flap interaction but doesn’t affect the σ70region 4/AsiA interactions were used. 
The bacterial two-hybrid assay was conducted and an increase in lacZ was observed 
when AsiA was introduced into cells containing fusion proteins. Furthermore, to verify 
that the AsiA- dependent increase in transcription required both AsiA/β-flap interaction 
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and the σ70region 4/AsiA, each interaction was disrupted utilizing a bacterial two-hybrid 
assay. 
 
Figure 5: The bacterial two-hybrid assay was used to detect protein-protein interaction 
between AsiA indicated as Y fused to λcI and β-flap indicated as X fused to the α-N 
terminal domain (αNTD). The interaction between X and Y activates transcription from 
the test promoter and drives the expression of lacZ. -35 and -10 are the promoter regions. 
lacZ encodes β-galactosidase. 
 
RNA polymerase 
Transcription in bacteria relies on a multi-subunit DNA-dependent RNA 
polymerase (RNAP) that binds with a key sigma (σ) factor to complete the holoenzyme. 
The complete holoenzyme has 6 subunits: β, β’, αI, αII, ω, and σ. The completion of the 
holoenzyme by σ factor allows the recognition of different promoters where specific 
initiation can begin (Yuan et al., 2008). RNAP is an essential enzyme controlling gene 
regulation where activity is modulated through transcription factors (TFs). TFs are 
proteins that interact with RNAP to control its activity and alter gene expression (Lee et 
al., 2012).   
RNAP core enzyme consist of 5 subunits: β, β’, αI, αII , and ω that are conserved 
in sequence, structure, and function in all organisms (Minakhin et al., 2001). The core 
enzyme structure is similar to a crab claw. β, β’, the two largest catalytic subunits, 
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comprise the bulk of the enzyme and make up the crab claw pincers (one on each end) 
(Vassylyev et al., 2007). The α subunit is split into 2 domains, the N-terminal and C-
terminal domains (αNTD and αCTD) that are connected by a flexible unstructured linker 
(Ross et al., 2003). The αNTD is the primary determinant for dimerization and interacts 
with β, β’ (Gaal et al., 1996). The αCTD interacts with UP elements (a component of the 
promoter region located upstream of the −35 hexamer), transcription activators, and is 
responsible for DNA binding. The ω subunit facilitates the binding of the β’ to αI, αII β to 
assemble the enzyme (Vrentas et al., 2005). Figure 6 depicts a simple cartoon of a 
bacterial RNAP and the subunits β, β’, αI, αII, and σ.  
 
Figure 6: Diagram of the bacterial RNAP holoenzyme showing the arrangements of β, β’, 
α, and σ indicating binding to promoter regions -10 and -35. A transcription start site is 





Sigma Factors  
Sigma (σ) factor, a subunit of bacterial RNAP, plays an essential role in specific 
promoter recognition to initiate transcription. σ binds to the core enzyme of RNAP (β, β’, 
αI, αII, ω) to complete the holoenzyme. σ factors play a critical role in various stages of 
transcription initiation that includes recognition of specific promoter elements, 
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stabilization of the open complex, and activation of RNA synthesis. In E. coli, there are 
two distinct families, the primary σ factor, σ 70, is responsible for the bulk of 
transcription during growth of cells consisting of 4 conserved regions (1-4). Each region 
has their own distinct function. Region 1 contains primary σ factors. Regions 2, 3, and 4 
interact with elements of the promoter –10 and –35 on RNAP (Paget, 2015).  Region 2 
interacts with the β’ clamp helices, also called the β' coiled-coil, forming the holoenzyme. 
Region 4 interacts with the β flap domain of RNAP (Banta et al., 2013). The other 
family, σ 54, requires ATP hydrolysis to aid in the melting of DNA to direct transcription 
(Paget, 2015). σ S is turned on when there are environmental stresses (Banta et al., 2013).  
Transcription Cycle 
Transcription is regulated in 3 stages; initiation, elongation, and termination. The 
synthesis of RNA is initiated at the promoter sequence by RNAP. The formation of the 
RNAP holoenzyme designated by a specific σ factor causes a closed complex. A 
transcription bubble will form allowing nucleotide triphosphates to bind. DNA is melted 
exposing the transcription start site, forming the open complex. RNAP directs the 
synthesis of short abortive transcripts before escaping into productive elongation 
(Zlatanova & van Holde, 2015). During elongation, the transcription complex may 
encounter pause sites and potential arrest sites at which the nascent RNA remains bound 
to the enzyme. Finally, upon reaching a termination sequence, RNAP releases the RNA 
transcript and dissociates from the DNA (Leibman & Hochschild, 2007). 
Transcription Factors  
 Transcriptional initiation is a crucial component for gene expression to occur. It is 
regulated by several factors including DNA sequences, proteins, and small molecules. 
19 
 
Initiation begins by the recruitment of the RNAP holoenzyme to a specific promoter 
upstream of a particular gene. The σ factor, a domain of RNAP, is responsible for 
specific promoter recognition guiding the holoenzyme to the promoter to initiate 
transcription. Several σ factors compete to bind to RNAP depending on environmental 
triggers and this sigma factor switching is responsible for differential expression. 
Transcription factors (TFs), another important bacterial regulator can activate or 
represses genes (Seshasayee et al., 2011). TFs can be classified into 3 types:  
I. TFs that influence the formation of the holoenzyme- Holoenzyme 
formation is not only controlled by σ factor concentrations, but also 
controlled by other proteins that guide σs to associate with RNAP. Anti σ-
factors regulate this process and also function to block particular σ-
containing holoenzyme by binding directly to σ factor blocking regions 2 
and/or 4 from making direct contact with their cognate RNAP binding 
determinants (Paget, 2015).  
II. DNA-dependent TFs- These TFs activate or repress transcription initiation 
in a DNA-dependent manner. TF activators bind to specific recognition 
sites located upstream of a promoter, making direct contact with one or 
more regions of RNAP. These regions of RNAP contacted in this manner 
are usually the α-CTD or σ region 4 and stabilize the initial binding of 
RNAP to the promoter. TF repressors function by binding to the promoter 
region and blocking RNAP from binding, inhibiting transcription 
(Feklístov et al., 2014).  
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III. DNA-independent TFs- TFs in E. coli such as Gre factors (GreA and 
GreB) and DksA can access RNAP without contacting DNA, influencing 
transcription at all stages of the transcription cycle. These factors affect 
specific kinetic pathways to the open complex formation regulating RNA 
output from specific promoters. For example, during elongation, Gre 
factors are present when RNAP undergoes a process called backtracking. 
This occurs when RNA 3′ end is no longer aligned with the active site 
(Haugen et al., 2008). Endonucleolytic cleavage is catalyzed by the active 
site and is greatly enhanced in the presence of Gre factors. The transcript 
cleavage Gre factors contain a C-terminal globular domain that binds to 
the entrance of the secondary channel and an N-terminal anti-parallel 
coiled-coil domain that extends into the channel. The tip is positioned near 
the displaced 3’ end of the RNA (Deighan & Hochschild, 2006). An 
endonucleolytic cleavage reaction is stimulated re-aligning the 3' end of 
the RNA in correct register with the enzyme’s active site facilitating 
promoter escape (Lang et al., 2004).  
Disruption of TF Interactions as Potential Therapeutic Strategies  
With a rise in antibiotic resistance, the development of new therapeutic strategies 
is required to combat infection. Microbial resistance is inevitable and has been 
complicating treatments in most bacterial infections for years. Currently, antibiotics 
target a small number of essential processes such as inhibition of cell wall synthesis, 
DNA replication, RNA transcription, protein synthesis, and folate synthesis. Virulence 
gene expression in vivo represents a potential target for antibiotic discovery that has not 
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yet been fully explored. (Hung et al., 2005).  Blocking the function of virulence factors 
could limit pathogen colonization, damage to host cells, and aid the host immune system 
in successful elimination of the pathogen.    
In Vibrio cholerae, a high-throughput screen of a 50,000-compound small 
molecule library from Chembridge Research Laboratories (Microformats) was used to 
identify inhibitors of virulence factor expression. Fifteen compounds were identified and 
had bacterial inhibitory function with minimal human cell toxicity. Virstatin, 1 of the 15 
compounds, was selected for further study. To confirm inhibitory functions, under in 
vitro virulence-inducing conditions, cholera toxin (CT) production, one of the major 
virulence factors in V. cholerae, was undetectable in the presence of virstatin. Toxin 
coregulated pilus (TCP) is coregulated with CT so virstatin’s ability to inhibit the 
expression and function of TCP was also measured (Hung et al., 2005). 
 TCP is thought to play a role in early attachment to intestinal epithelium and is 
required for intestinal colonization in an infant mouse model of cholera. Virstatin was 
found to inhibit the transcriptional regulator ToxT, preventing the expression of CT and 
TCP, protecting infant mice from intestinal colonization by V. cholerae. These results 
demonstrate that drugs such as virstatin can be used, like conventional antibiotics, to treat 
bacterial infections (Hung et al., 2005). Other small molecule inhibitors of virulence 
regulation have been reported, including inhibitors of a two-component regulator of 
alginate synthesis in P. aeruginosa and inhibitors of quorum sensing in Staphylococcus 
aureus and P. aeruginosa. The bacterial two-hybrid assay was used to understand how 
virstatin works. Identifying inhibitors of virulence factors represent another way to target 
bacterial pathogens (Hung et al., 2005).  
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Patients suffering from cystic fibrosis (CF) have an increased chance of having P. 
aeruginosa infections. P. aeruginosa infections can produce copious amounts of the 
exopolysaccharide alginate contributing to pathogenesis. Alginate prevents phagocytosis 
and inhibits neutralization/opsonization by antibodies. Expression of alginate genes in P. 
aeruginosa are regulated by several proteins and a two-component system. These 
regulatory proteins are AlgR1 and AlgR2. AlgR1 binds to DNA and activates gene 
expression of alginate and AlgR2 is a kinase that phosphorylates AlgR1. Twenty five 
thousand synthetic compounds were screened and 15 were identified as inhibitors of algD 
transcription in vivo in whole cells (Roychoudhury et al., 1993). This is important 
because algD is a tightly regulated gene encoding GDP-mannose dehydrogenase, which 
is critical for P. aeruginosa alginate biosynthesis (Wozniak & Ohman, 1994).  
These 15 compounds were also found to inhibit alginate synthesis to some degree. 
Two types of inhibitors on the effects of AlgR1 and AlgR2 were further investigated. The 
inhibitory effect of these compounds on the known kinases of other two-component 
systems was also examined. Out of the 15 inhibitory compounds, 4 of these were 
identified to inhibit or repress the activation of the algD promoter in vivo. These 
inhibitors could lead to the correlation of the phosphorylation/dephosphorylation of the 
AlgR2-AlgR1 complex and the DNA-binding activity of AlgR1 with their physiological 
roles in regulating alginate gene expression in P. aeruginosa. The overall goal is to 
develop non-toxic inhibitors that target signal transduction pathways in genes associated 
with virulence (Roychoudhury et al., 1993).   
A study performed by Turner et al., 2014 used new technologies including 
RNASeq and TnSeq to explore what P. aeruginosa genes are essential for acute and 
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chronic infections in murine models. RNASeq allows quantitation of transcript levels and 
TnSeq reports on the contribution of specific genes toward fitness in vivo. Remarkably, 
the RNASeq analysis revealed that cues sensed by the bacteria in both types of infections 
are similar. Transcripts encoding known virulence factors were being expressed such as 
proteases, pyochelin, and rhamnolipids synthesis. These virulence factors were strongly 
upregulated in both acute and chronic infections. However, psl biosynthetic genes were 
strongly downregulated. Psl polysaccharide is the main matrix component in P. 
aeruginosa biofilms. This was a surprising find because biofilms are thought to be 
associated with the development of chronic infections (Crousilles et al., 2015). 
TnSeq analysis revealed even more interesting findings. The type III and VI 
secretion systems were found to be important for chronic infections, but not acute 
infections. This was a surprising find because laboratory experiments have shown in vitro 
that the type III secretion is thought to be associated with acute infections whereas the 
type VI secretion systems are thought to be associated with chronic infections. P. 
aeruginosa was previously thought to be highly dependent on amino acids due to the 
abundance of proteases encoded in its genome. RNASeq analysis in Turner et al., 2014 
found that P. aeruginosa is particularly partial to long-chain fatty acids. It was found that 
enzymes involved in fatty acid metabolism are required for survival in acute and chronic 
murine infection models (Crousilles et al., 2015). 
The glyoxylate shunt pathway allows cells to utilize simple carbon compounds as 
a carbon source when complex sources such as glucose are not available. It was found 
that transcripts encoding enzymes involved in the oxidative decarboxylation steps of the 
tricarboxylic acid (TCA) cycle were downregulated. The transcript encoding the first 
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enzyme of the glyoxylate shunt (aceA) was upregulated. Previous studies have noted the 
importance of the glyoxylate shunt pathway. Fahnoe et al., 2012 inactivated both aceA 
and glcB in P. aeruginosa causing the glyoxylate shunt pathway to be completely 
inactivated. The double mutant was completely cleared by 48-hour post-infection in a 
mouse pulmonary infection model indicating that the shunt is essential for colonization in 
vivo. It is hopeful that with newly emerging evidence of genes activated during acute and 
chronic infections new antipseudomonal compounds might be discovered. Developing 
inhibitors for fatty acid metabolism or the glyoxylate shunt pathway could be an avenue 
of antimicrobial design however; this may be more difficult to design inhibitors because 

























Experimental Design Outline 
Given that RNAP is highly conserved between E. coli and P. aeruginosa, the E. 
coli RNAP coreome can be used to study RNAP-protein interactions in P. aeruginosa. 
This assay could be used as a platform in the future to identify TFs from P. aeruginosa 
that interact with RNAP. Proteins that modulate RNAP activity could be used as targets 
for novel anti-pseudomonal drugs.  
RNAP coreome 
It is important to note that the bacterial two-hybrid assay used in this study 
utilized elements of E. coli RNAP to determine interactions with P. aeruginosa proteins. 
Although E. coli and P. aeruginosa thrive in different environments; E. coli typically 
lives in the gut of humans and P. aeruginosa thrives in immune compromised individuals 
and moist environments, they belong to the same class of bacteria 
(Gammaproteobacteria). In general, RNAP is a highly conserved enzyme among bacteria. 
Alignments of the amino acids of each piece of the E. coli RNAP coreome to specific 
domains of P. aeruginosa RNAP have shown a high degree of similarity and are 
represented in Table 2. Actual amino acid alignments are in Appendix A. The five 
subunits of RNAP were broke down into 38 surface exposed independently folded 
fragments. These regions were chosen based on crystal structure and biochemical 
analysis. Each fragment was individually cloned in frame with the gene encoding the λcI 
DNA binding protein in plasmid pAC-cI. The result was a pAC-λcI-RNAP coreome 
plasmid library capable of expressing 38 different λcI-RNAP protein fusions.  
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Table 2: Similarity of E. coli RNAP fragment in the coreome with the corresponding P. 
aeruginosa RNAP fragments utilizing pBLAST. 
 
E. coli RNAP 
fragment  
E. coli Fragment 
Length in Amino 
Acids 
% similarity to 
P. aeruginosa 
α 2-235 233 82 
α 249-329 80 99 
β 1-151 150 88 
β 1-235 234 89 
β’ 25-104 80 96 
β’ 114-190 76 92 
β’ 140-235 96 86 
β 151-451 300 85 
β’ 193-230 37 84 
β 235-650 415 86 
β’ 249-328 80 100 
β’ 264-308 45 100 
β’ 370-416 46 94 
β 450-530 80 92 
β’ 516-573 57 91 
β 528-589 61 93 
β 528-656 128 88 
β’ 576-634 58 83 
β 587-656 69 83 
β’ 648-701 53 83 
β 650-950 300 92 
β 665-798 133 87 
β 703-795 92 92 
β’ 735-790 55 100 
β’ 820-882 62 90 
β 829-930 101 93 
β 831-1059 228 82 
β 930-1059 129 75 
β’ 944-1021 52 78 
β’ 944-1133 189 81 
β 950-1342 392 87 
β’ 1023-1128 105 82 
β 1137-1226 89 85 
β’ 1137-1243 106 93 
β’ 1154-1212 58 93 
β’ 1261-1307 46 84 
σ 94-448 354 84 





To test the hypothesis that an E. coli RNAP coreome could be used to study 
interactions with P. aeruginosa proteins, a series of positive control experiments were 
designed. These positive control experiments were based on the limited studies of RNAP-
protein interaction in P. aeruginosa. The  P. aeruginosa protein, AlgQ, is known to 
interact with regions 2 and 4 of σ70 of P. aeruginosa RNAP (Yuan et al., 2008). We 
hypothesize that in a coreome assay AlgQ should interact with the represented regions 2 
and 4 of σ70.  
The NusG TF has been shown in E. coli to interact with RNAP β’ clamp helices 
(Burmann et al., 2010). Utilizing bioinformatics analysis, a NusG homolog was found in 
P. aeruginosa and was selected as a control. We hypothesize that P. aeruginosa NusG 
should interact with the RNAP β’ clamp helices elements of the E. coli RNAP coreome 
in the same manner. Based on Table 2, there are some subtle differences in P. aeruginosa 
RNAP compared to E. coli RNAP. However, due to the high degree of similarity of the 
RNAP in these organisms, it is reasonable to suspect P. aeruginosa proteins will interact 
in a similar fashion with the E. coli RNAP.  
Selecting potential P. aeruginosa protein targets for RNAP interactions 
 E. coli proteins that have been shown to either directly or indirectly interact with 
RNAP are listed in Table 1. The list was downloaded from the IntAct Molecular 
Interaction Database-www.ebi.ac.uk/intact. IntAct provides an open source database 
system and analysis tools for molecular interaction data. All protein interactions are 
derived from literature curation or direct user submissions and are freely available. 
Because E. coli and P. aeruginosa are in the same class of bacteria, it is possible that 
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these proteins could be functioning as TFs in both organisms. Compared to E. coli, much 
less is known about the TFs in P. aeruginosa and how they (and other proteins) interact 
with RNAP. Utilizing bioinformatic analysis, homologs to these E. coli proteins were 
identified in P. aeruginosa.  
Initially, sixteen P. aeruginosa homologs were selected for further analysis in the 
bacterial two-hybrid assay to identify potential interactions with RNAP (see Table 1). 
Sixteen potential target P. aeruginosa TF genes were cloned into the pBRα plasmid 
expression vector that created fusions of the target proteins to the α-subunit of RNAP.  
Expression of the target TF fusion proteins were under the control of an IPTG inducible 
promoter. The RNAP coreome was fused to λcI. Expression of the RNAP coreome fusion 
proteins were also under the control of an IPTG inducible promoter. Both bait and prey 
plasmids were transformed into a β-galactosidase reporter strain FW102 OL2-62. The 16 
P. aeruginosa proteins were tested against each member of the RNAP coreome library in 
a 96 well format. Any proteins that directly interacted with a piece of the RNAP coreome 
were then further investigated. 
Validation of target protein interactions with RNAP coreome   
Initially 16 P. aeruginosa proteins were screened in the bacterial two-hybrid 
assay, 3 were shown to interact with fragments of RNAP. These 3 proteins were chosen 
for further analysis. If an interaction between a P. aeruginosa protein and RNAP were 
real, then it would be predicted that increasing the amount of the interacting proteins 
would result in higher β-gal activity in the reporter strain. Liquid β-gal assays were then 
performed with the reporter strain transformed with a plasmid expressing a specific P. 
aeruginosa protein and a plasmid expressing a specific piece of the RNAP coreome. 
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 The transformed reporter strains were then grown in liquid broth media with 
increasing amounts of IPTG. Another validation test was performing the bacterial two-
hybrid assay in the other orientation whereby fusing the P. aeruginosa protein of interest 
to cI while the interacting piece of the RNAP coreome was fused to the α-subunit of 
RNAP. If the interaction between the two proteins are real, then the prediction would be 
that the orientation of the fusion proteins should not matter.    
Analysis of P. aeruginosa Tig with the RNAP coreome. 
Out of 3-potential P. aeruginosa proteins that were shown to interact with RNAP, 
one was chosen for additional study. Further investigation focused on the protein Tig. In 
the two-hybrid assay, Tig had the strongest interaction with RNAP.  Tig is also a well-
categorized chaperone protein with a defined domain structure (Hoffmann et al., 2010). 
Previous results in this work showed that Tig interacted with pieces of RNAP. However, 
the sites of interaction between Tig and RNAP were not known. To determine the surface 
of interaction between Tig and RNAP, Tig was spilt into its 3 domains. Each domain was 























Bacterial Strains and Plasmids: 
Table 3: A list of the bacterial strains and plasmids used in the study. 




DH5α E. coli host strain for 
plasmid construction 
Kanamycin Yuan et al., 2008 
FW102 OL2-62 
 
FW102 harboring an F′ 
Kan bearing test 
promoter placOL2-62 
linked to lacZ 
Kanamycin  Deaconescu et al. 
2006 




synthesis of the λcI 
protein fused via three 
alanines to 38 different 
RNAP fragments. See 
Table 2 for full details 
of the RNAP fragments 
Chloramphenicol Supplied by: 
Padraig Deighan, 
Emmanuel College 
pACλcI IPTG inducible 
expression of λcI 
protein 
Chloramphenicol Dove et al., 1997 
pACλcI-βflap PlacUV5-directed 
synthesis of the λcI 
protein fused via three 
alanines to residues 
831-1057 of the β 
subunit of E. coli RNAP  
Chloramphenicol Supplied by: 
Padraig Deighan, 
Emmanuel College 
pACλcI-ClpA IPTG inducible 
expression of λcI-ClpA 
fusion protein 
Chloramphenicol This study 
pACλcI-DppF IPTG inducible 
expression of λcI-DppF 
fusion protein 
Chloramphenicol This study 
pACλcI-Tig IPTG inducible 
expression of λcI-Tig 
fusion protein 
Chloramphenicol This study 
pBRα IPTG inducible 
expression of RNAP α-
subunit 
Carbenicillin Dove et al., 1997 
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pBRα-β flap Expression of RNAP 
alpha NTD fused to E. 
coli RNAP subunit beta, 
aa 831-1057 (β-flap). 
Can be cut with NotI 
and BamHI to replace 
β-flap with a moiety of 
interest. 
Carbenicillin Supplied by: 
Padraig Deighan, 
Emmanuel College 
pBRα-β' 735-790  IPTG inducible 
expression of RNAPα-β' 
735-790 fusion protein 
Carbenicillin Supplied by: 
Padraig Deighan, 
Emmanuel College 
pBRα-β 450-530   IPTG inducible 
expression of RNAPα-β 
450-530   fusion protein 
Carbenicillin Supplied by: 
Padraig Deighan, 
Emmanuel College 
pBRα-β 829-930  IPTG inducible 
expression of RNAPα-β 
829-930 fusion protein 
Carbenicillin Supplied by: 
Padraig Deighan, 
Emmanuel College 
pBRα-β 831-1059   IPTG inducible 
expression of RNAPα-β 
831-1059 fusion protein 
Carbenicillin Supplied by: 
Padraig Deighan, 
Emmanuel College 
pBRα-β' 114-190  IPTG inducible 
expression of RNAPα-β' 
114-190 fusion protein 






expression of RNAPα-β 
1137-1226 fusion 
protein 






synthesis of the αNTD 
protein fused via three 
alanines to E. coli σ70 
region 4 (residues 528-
613 of σ70). The σ70 
moiety also carries the 
D581G substitution  
Carbenicillin Supplied by: 
Padraig Deighan, 
Emmanuel College 
pBRα-AlgQ IPTG inducible 
expression of RNAPα-
AlgQ fusion protein 
Carbenicillin Yuan et al., 2008 
pBRα-AtpD  IPTG inducible 
expression of RNAPα-
AtpD fusion protein 
Carbenicillin This study 
pBRα-ClpA IPTG inducible 
expression of RNAPα-
ClpA fusion protein 
Carbenicillin This study 
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pBRα-ClpB IPTG inducible 
expression of RNAPα-
ClpB fusion protein 
Carbenicillin This study 
pBRα-DppF IPTG inducible 
expression of RNAPα-
DppF fusion protein 
Carbenicillin This study 
pBRα-GcvP IPTG inducible 
expression of RNAPα-
GcvP fusion protein 
Carbenicillin This study 
pBRα-Lon IPTG inducible 
expression of RNAPα-
Lon fusion protein 
Carbenicillin This study 
pBRα-NusG IPTG inducible 
expression of RNAPα-
NusG fusion protein 
Carbenicillin This study 
pBRα-PstB IPTG inducible 
expression of RNAPα-
PstB fusion protein 
Carbenicillin This study 
pBRα-PyrG IPTG inducible 
expression of RNAPα-
PyrG fusion protein 
Carbenicillin This study 
pBRα-RhlE IPTG inducible 
expression of RNAPα-
RhlE fusion protein 
Carbenicillin This study 
pBRα-SdhA IPTG inducible 
expression of RNAPα-
SdhA fusion protein 
Carbenicillin This study 
pBRα-SpoT IPTG inducible 
expression of RNAPα-
SpoT fusion protein 
Carbenicillin  
This study 
pBRα-SutA IPTG inducible 
expression of RNAPα-
SutA fusion protein 
Carbenicillin This study 
pBRα-Tig  IPTG inducible 
expression of RNAPα-
Tig fusion protein 





Tig domain 1 fusion 
protein 





Tig domain 1+2 fusion 
protein 





Carbenicillin This study 
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Tig domain 2+3 fusion 
protein 





Tig domain 3 fusion 
protein 
Carbenicillin This study 
pBRα-TsaD IPTG inducible 
expression of RNAPα-
TsaD fusion protein 
Carbenicillin This study 
 
Media:  
LB agar was made by adding 12.5 g of LB broth powder (VWR) supplemented with 7.5 g 
of agar (VWR) per 500 mL of water. LB broth was made my adding 12.5 g of LB broth 
powder (VWR) per 500 mL of water. LB-2X broth was made by adding 25 g of LB broth 
(VWR) per 500 mL of water. When antibiotic selection was required, the appropriate 
media was supplemented with 25 µg/mL of chloramphenicol for pAC-cI plasmids, and 
100 µg/mL carbenicillin for pBRα plasmids. DH5α were selected for with 50 µg/mL 
kanamycin. For the bacterial two-hybrid assay FW102 OL2-62 cells harboring the pAC-
cI and pBRα plasmid, were selected for with 50 µg/mL kanamycin, 25 µg/mL 
chloramphenicol, and 100 µg/mL carbenicillin.   
Competent Bacterial Cells: 
Chemically competent cells of DH5α and FW102 OL2-62 were made using the protocol 
described in Dove et al., 1997. 
Transformation of Plasmid DNA into E. coli DH5α Cells 
To transform plasmid DNA into E. coli DH5α cells, the DH5α competent cells were 
thawed on ice. One hundred microliters of cells were added to a sterile microcentrifuge 
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tube and placed on ice. One microliter of desired plasmid was then added to the 
competent cells, and incubated on ice for 30 minutes. After 30 minutes cells were heat-
shocked at 42 °C for 2 minutes and then placed back on ice for 2 minutes. One milliliter 
of LB was then added to each centrifuge tube and incubated at 37 °C for 1 hour. One 
hundred microliters of the transformation was then plated on LB media containing 
appropriate antibiotics. Plates were incubated at 37 °C overnight.  
Plasmid DNA Isolation: 
Overnight cultures were made by inoculating one colony into LB broth media with 
appropriate antibiotics. Following growth, the cells (7 mL) were pelleted at 4,000 g for 
10 minutes at 4 °C. Plasmid preparations were then performed by the E.Z.N.A Plasmid 
DNA Mini Kit I (OMEGA) using the manufacture’s protocol. 
Cloning Genes into the Bacterial Two-Hybrid Plasmids: Primers and PCR 
Primers were designed using DNA analysis software (a plasmid editor, ApE). Primers 
were ordered that added a 5’-NotI site (GCGGGCCG, and an extra nucleotide to keep the 
coding region in-fame) and 3’-BamHI site (GGATCC) flanking the gene of interest. PCR 
was utilized to amplify the target gene with the added restriction sites. The forward 
primer for cloning by PCR had the sequence 5'-gaagGCGGCCGC-followed by the start 
codon of the gene of interest and approximately 17 additional nucleotides. The 
nucleotides in lower case are terminal nucleotides that function as a binding site for the 
restriction endonucleases. The reverse primer for cloning by PCR had the sequence 5'-
gaagGGATCC. The reverse primer incorporated approximately 17 nucleotides upstream 
of the stop codon of the gene of interest, the stop codon, and a BamHI recognition site 
GGATCCatat (BstYI or BglII are also compatible and can be cloned into BamHI-digested 
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pACλcI-β-flap or pBRα-β flap backbones). NotI is a 8bp cutter 5'-GCGGCCGC-3'. Since 
the protein of interest is going to be on the C-ter of the fusion proteins adding an extra 
base onto the NotI site to maintain the reading frame (e.g., ‘A’). This new NotI site, 
GCGGCCGCA, is translated into a 3 x Alanine linker. All primers were ordered form 




















Table 4: Table of forward and reverse primers used in PCR. The bolded letters indicate 
restriction sites. The underline nucleotides are the terminal nucleotides added to provide a 
binding site for the restriction endonucleases.  
Gene of 
Interest 













































































































PCR was performed using a KOD extreme kit (Novagen) in a 100 µL reaction mix. The 
reaction mix included 50 µL of 2X Xtreme buffer, 20 µL of 2 mM dNTPs, 3 µL of 
forward and reverse primers at 10 mM, 10 µL of PAO1 Pseudomonas aeruginosa 
chromosomal DNA (approximately 10 nanograms), 12 µL of water, and 2 µL of KOD 
extreme Hot Start DNA polymerase. 
PCR Reaction Conditions: 
Step 1: 94 °C for 2 minutes 
Step 2: 98 °C for 15 seconds 
Step 3. 56 °C for 30 seconds. Annealing temperature is dependent on amplicon, see Table 
5.   
Step 4. 68 °C for 1 minute. Extension time is dependent on amplicon, see Table 5.  
Step 5. go to step 2, repeat 28 times 
Step 6. 68 °C 5 minutes 













Table 5: Table of the annealing temperature and extension time of each amplicon. 
 




algQ (control) (Yuan et al., 2008) (Yuan et al., 2008) 
atpD 59 1 
clpA 66 2.5 
clpB 64 2.5 
dppF 67 1 
gcvP 66 3 
Lon 58 2.5 
nusG (control)  56 1 
pstB 67 1 
pyrG 62 1.75 
rhlE 65 2 
sdhA 60 2 
Spot 66 2.25 
sutA (control) 66 45 seconds 
Tig 64 1.5 
tsaD 68 1.25 
 
PCR Clean-Up and DNA Gel Electrophoresis  
PCR clean-up was performed by the Gel/PCR DNA Fragments Extraction Kit (IBI 
SCIENTIFIC) using the manufactures protocol. Following PCR-clean up DNA was then 
electrophoresed on a 1% agarose gel (VWR) to verify PCR amplification product size. 
When needed, DNA was isolated from a gel slice using the Gel/PCR DNA Fragments 






Construction of pBRα Expression Vectors 
PCR products were digested with NotI and BamHI and ligated into pBRα expression 
plasmid digested with NotI and BamHI. If the gene of interest contained an endogenous 
BamHI site then the PCR product was digested with NotI and BglII. DNA digested with 
BglII and BamHI leave complementary over hangs. This created plasmids that upon 
induction with IPTG (GoldBio), lead to the production of proteins of interest fused to the 
αNTD of RNAP. 
Construction of pACλcI Expression Vectors 
PCR products were digested with NotI and BamHI and ligated into the pACλcI 
expression plasmid digested with NotI and BamHI. If the gene of interest contained an 
endogenous BamHI site then the PCR product was digested with NotI and BglII. DNA 
digested with BglII and BamHI leave complementary over hangs. This created plasmids 
that upon induction with IPTG (GoldBio), lead to the production of proteins of interest 
fused to the to the DNA binding domain of λcI. 
Target Amplicon Digestion 
The 30 µL digestion reaction mix included 15 µL of PCR product from the target gene of 
interest, 1 µL of NotI and BamHI, 3 µL of CutSmart buffer 10X concentrate, and 10 µL 
of water. For genes that had an endogenous BamHI site, cloning was performed with 
BglII. The 30 µL digestion reaction mix included 15 µL of PCR product from the target 
gene of interest, 1 µL of NotI and BglII or BamHI, 3 µL of buffer 3.1, and 10 µL of 




Digestion of Plasmid Backbone pBRα β-flap and pACλcI  
The 30 µL digestion reaction mix included 15 µL of pBR β-flap or pACλcI- β-flap, 1 
µL of NotI and BamHI, 3 µL of CutSmart buffer 10X concentrate, and 10 µL of water. 
All digestion reactions were incubated at 37 °C for one hour. 
Ligation Protocol of Digested PCR Products into Plasmid Backbones  
The 30 µL ligation reaction mix included 20 µL of NotI/BamHI–digested PCR product 
from the gene of interest, 6 µL of NotI/BamHI–pBR β-flap or NotI/BamHI– pACλcI β-
flap, 3 µL 10X buffer for T4 DNA Ligase with 10mM ATP, and 1 µL of T4 DNA ligase 
from New England Bio Labs. The ligation reactions were incubated at room temperature 
for 15 minutes and then placed at 4 °C overnight. 
DNA Sequencing 
All plasmids generated in this study were sequenced (Genewiz Inc.) to verify that fusion 
constructs were correct.  
Screening for Potential Proteins that Interact with RNAP Coreome 
We used a bacterial two-hybrid assay to identify the transcription factors-binding site on 
RNAP for putative RNAP-associated proteins. The transcription factors were selected 
based on data in the E. coli protein-protein interaction database (Table 1). From this list 
of RNAP-associated proteins, we selected homologous proteins from P. aeruginosa that 
had the highest degree of similarity with the E. coli proteins (Table 6).  
Co-Transformation for a Coreome Assay 
The reporter strain FW102 OL2-62 was co-transformed with each individual plasmid 
from the coreome library and an expression plasmid containing a P. aeruginosa gene of 
interest fused to α-subunit of RNAP. Four microliters of an expression plasmid 
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containing a P. aeruginosa gene of interest were added to a microcentrifuge tube of 
competent cells (reporter strain FW102 OL2-62). Sixteen microliters of competent cells 
with gene of interest were added in a 96 well-plate that contained 39 different plasmids of 
RNAP. The 40th well contained water for a negative control. The 96 well-plate was kept 
on ice for 30 minutes and then heat shocked at 42 °C for 1 minute. The plate then sat on 
ice for 5 minutes. One hundred microliters of 2X LB (VWR) were added to each well and 
incubated for 1.5 hours. After incubation 120 µl of the co-transformation were added to a 
new 96 well plate containing 600 µl LB broth (VWR) with 50 µg/mL kanamycin, 25 
µg/mL chloramphenicol, and 100 µg/mL carbenicillin and 5 µM of IPTG. It was then 
placed on a 96-well microplate shaker (VWR) at 900 rpm overnight at 37 °C. β-
galactosidase assay to measure protein-protein interactions were done as described below 
using a SpectraMAX plate reader (Molecular Devices).   
Co-Transformation for β-Galactosidase Assay of Target and Known Interaction 
One hundred microliters of competent cells (FW102 OL2-62) and 2 µl of the bait and 
prey plasmids were added to a microcentrifuge tube. The microcentrifuge tube was kept 
on ice for 30 minutes. After 30 minutes the microcentrifuge tube was heat shocked at 42 
oC for 1 minute and then kept on ice for 5 minutes. One milliliter of 2X LB nutrient broth 
was then added to the microcentrifuge tube and incubated at 37 ºC for 1.5-2 hours. The 
microcentfigue tube was then pipetted out in equal volumes in a 96 well-plate with 600 µl 
of selective media broth containing 50 µg/mL kanamycin, 25 µg/mL chloramphenicol, 
and 100 µg/mL carbenicillin with various concentrations of IPTG. The 96 well-plate was 
then placed on a plate shaker (VWR Advanced Vortex Mixer) at 500 rpm overnight. β-
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galactosidase assays to measure protein-protein interactions were done as described 
below.   
β-Galactosidase Assays 
β-galactosidase assays were performed with microtiters plates and a microtiter plate 
reader (EPOCH/2 Microplate Reader SN 1410067) as described in Thibodeau et al., 
2004. The ortho-Nitrophenyl-β-galactosidase (ONPG) used was purchased from 
GoldBio. In experiments performed in the presence of increasing IPTG, assays were 








































P. aeruginosa and E. coli are closely related, both belong to the class 
Gammaproteobacteria. Twenty-two bacterial genomes of pooled ORFs were compared to 
P. aeruginosa and the sequences were aligned using BLASTP44. It was found that nearly 
half of the best hits above a stringent comparison threshold were to E. coli (Stover et al., 
2000). Half of the ORFs in E. coli therefore have homologs in P. aeruginosa. No other 
organisms tested accounted for even 10%. Although closely related, P. aeruginosa has a 
significantly larger genome resulting in greater genetic complexity (Stover et al., 2000). 
The similarities of these two organisms should allow us to utilize elements of E. coli 
RNAP, known as the RNAP coreome, to determine interactions with P. aeruginosa 
proteins.  
The RNAP coreome consist of 38 surface exposed regions of RNAP. The 
coreome was constructed based on the high-resolution structure of the bacteria Thermus 
aquaticus RNAP and alignments to E. coli RNAP. Results suggested that E. coli β RNAP 
can be parsed into 10 sub-domains. Analysis of the E. coli β’ subunit of RNAP suggested 
that it could be parsed into 18 sub-domains. To identify where a regulatory factor (or 
other protein) binds to RNAP, experiments can be performed where the regulatory factor 
of interest is fused to the α sub-domain of RNAP and activates transcription in the 
presence of any RNAP sub-domain fused to the λcI domain (Nickels, 2009). In addition, 
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the coreome contains two α pieces of RNAP, α 2-235 and α 249-325 which corresponds 
to regions 2 and 4 of σ70.  
 A bacterial two-hybrid assay can be used to validate protein-protein interactions 
between the regulatory factor of interest and a sub-domain of RNAP. It can also be used 
to identify amino acid substitutions in the RNAP sub-domain or the regulatory factor that 
specifically disrupts (or enhances) the protein–protein interaction (Nickels, 2009). In 
general, RNAP is a highly conserved enzyme among bacteria. Alignments of the amino 
acids of each piece of the E. coli RNAP coreome to specific domains of P. aeruginosa 
RNAP have shown to have a high degree of similarity (Table 2). Based on the high 
degree of similarity to the E. coli RNAP coreome we hypothesized that the E. coli RNAP 
coreome could be utilized to study RNAP-interacting proteins in P. aeruginosa. 
E. coli RNAP Coreome Interactions with P. aeruginosa Proteins Known to Interact 
with RNAP. 
P. aeruginosa protein AlgQ 
To validate that the E. coli RNAP coreome is suitable to study P. aeruginosa 
proteins, two well-studied TFs in P. aeruginosa were chosen that had previously 
described interactions with RNAP. The P. aeruginosa protein, AlgQ, is known to interact 
with regions 2 and 4 of σ70 of P. aeruginosa RNAP. AlgQ regulates the production of key 
virulence factors such as alginate, and pyocyanin (Yuan et al., 2008). To test whether 
AlgQ interacted with any pieces of the E. coli RNAP coreome, a bacterial two-hybrid 
assay was used with an α-AlgQ fusion protein and λcI fusion proteins of the E. coli 
RNAP coreome. The α-AlgQ fusion protein activated transcription from the test promoter 
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in the presence of pAcI-σ 528-613 (σ70 R4) and had ~6-fold increase in β-galactosidase 
activity compared to α-AlgQ + λcI control (Figure 7).  
Within the σ 528-613 region of the E. coli RNAP coreome there was a 93% 
similarity to the corresponding RNAP region of P. aeruginosa (Table 2). The α-AlgQ 
fusion protein activated transcription from the test promoter in the presence of pAcI-α 2-
235 and had a ~3-fold increase in β-galactosidase activity compared to α-AlgQ + λcI 
control. Within the α 2-235 region of the E. coli RNAP coreome there was an 82% 
similarity found in the corresponding RNAP region of P. aeruginosa (Table 2). These 
results indicated that α-AlgQ interacted with pAcI-α 2-235 and pAcI-σ 528-613 of the 
RNAP coreome. The interaction between AlgQ and pAcI-σ 528-613 is what was 
expected because AlgQ is known to interact with region 4 of σ70 of P. aeruginosa RNAP 
(Yuan et al., 2008). In the E. coli RNAP coreome we only see an interaction with region 
4. This is likely due to the fact that σ70 R4 of E. coli has a 93% similarity to the 
corresponding RNAP region of P. aeruginosa compared to an 84% similarity in σ70 R2.  
Slight differences in σ70 R2 between these two organisms could explain why an 
interaction was not detected between AlgQ and E. coli σ70 R2. 
pAcI-α 2-235 appears to be a sticky protein fragment that has been shown to 
generate non-specific binding in a number of two-hybrid assays. Out of the 16 P. 
aeruginosa proteins tested against the E. coli RNAP coreome, 5 interacted with pAcI-α 2-




Figure 7: RNAP coreome screen displaying AlgQ interactions with RNAP-α 2-
235 R45A and σ 528-613 D581G. Diagram shows β-galactosidase transcription 
activation of a bacterial two-hybrid assay. This assay depicts two interactions of 
an α-fusion of AlgQ with cI-fusions of the RNAP coreome. The dashed line 
indicates the average background level of β-galactosidase activity. pBRα and 
pACλCI plasmids directed the synthesis of fusion proteins under the control of 
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain 
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase 
activity. β-galactosidase activity is expressed in Miller units indicated on the y-
axis. The x-axis indicates the individual E. coli RNAP coreome fragments being 
expressed in the reporter strain. 
 
P. aeruginosa Protein NusG 
NusG is a well-studied highly conserved TF that has been shown in E. coli to 
interact with RNAP β’ clamp helices. NusG activates Rho transcription termination factor 
in vitro and is necessary for most Rho-mediated termination events in vivo (Burmann et 
al., 2010). NusG-NTD binds to RNAP and increases the rate of transcription elongation 
but cannot stimulate termination (Burmann et al., 2010). In E. coli, NusG is an essential 
bacterial regulator of the RNAP with a size of 20.5 kDa. NusG is a two-domain protein 




Utilizing bioinformatics analysis, a NusG homolog was found in P. aeruginosa. 
To test whether Pseudomonas aeruginosa NusG interacted with any pieces of the E. coli 
RNAP coreome, a bacterial two-hybrid assay was used with an α-NusG fusion protein 
and λcI fusion protein of the RNAP coreome. The α-NusG fusion protein activated 
transcription from the test promoter in the presence of pAcI-β’249-328, and had a ~2.5-
fold increase in β-galactosidase activity compared to α-NusG + λcI control. α-NusG 
fusion protein also activated transcription from the test promoter in the presence of pAcI-
β’264-308, and had a ~3-fold increase in β-galactosidase activity compared to α-NusG + 
λcI control (Figure 8). β’249-328 and β’264-308 regions of the E. coli RNAP coreome 
have 100% similarity in the corresponding RNAP region of P. aeruginosa and are 
overlapping fragments (Table 2). These results indicated that P. aeruginosa α-NusG 
interacted with pAcI-β’249-328 and pAcI-β’264-308 of the E. coli RNAP coreome which 
is what would be predicted since it is known that E. coli NusG interacts with β’ clamp 
helices (Burmann et al., 2010).  
These control experiments with AlgQ and NusG suggest that the E. coli RNAP 
coreome can be used to detect RNAP-interacting proteins in P. aeruginosa. It was 
demonstrated that P. aeruginosa AlgQ and NusG interacted with the previously known 
RNAP elements expressed in E. coli. Since P. aeruginosa AlgQ and NusG interacted as 
predicted with elements of the E. coli RNAP coreome, 16 additional P. aeruginosa 
protein targets that had previously undescribed interactions with RNAP in P. aeruginosa 




Figure 8: RNAP coreome screen demonstrating NusG interactions with β’249-328 
and β’264-308. Diagram shows β-galactosidase transcription activation in a 
bacterial two-hybrid assay. This assay depicts interaction of an α-fusion of P. 
aeruginosa NusG with cI-fusion of the E. coli RNAP coreome. The dashed line 
indicates the average background level of β-galactosidase activity. pBRα and 
pACλCI plasmids directed the synthesis of fusion proteins under the control of 
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain 
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase 
activity. β-galactosidase activity is expressed in Miller units indicated on the y-
axis. The x-axis indicates the individual E. coli RNAP coreome fragments being 
expressed in the reporter strain. 
 
Screening 16 P. aeruginosa Target Proteins with Previously Undescribed RNAP 
Interactions for Interactions with the E. coli RNAP coreome.   
 
A list of E. coli proteins were shown to be associated with RNAP. The 
information was gathered from IntAct Molecular Interaction Database-
www.ebi.ac.uk/intact (Table1). A BLAST search was performed through 
Pseudomonas.com to identify proteins from this E. coli list that had the highest similarity 
(greater than 75%). P. aeruginosa proteins were chosen based on high similarity, 
previously undescribed interaction with P. aeruginosa RNAP, and the lack of the NotI 
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site. The NotI site was critical for cloning into the pBRα expression vector. These 16 
genes were cloned into the pBRα expression plasmid. 
Initially, 16 target P. aeruginosa proteins with fusions to the pBRα expression 
vector were screened in the bacterial two-hybrid assay tested against the fusion of λcI of 
the RNAP coreome. Upon testing target proteins against the RNAP coreome only 3 
proteins had a direct interaction with RNAP. α-ClpA, α-DppF, and α-Tig all interacted 
with RNAP. α-AtpD, α-ClpB, α-GcvP, α-Lon, α-PstB, α-PyrG, α-RhlE, α-SdhA, α-SpoT, 
α-SutA, and α-TsaD had no significant interaction with the RNAP coreome. See 
Appendix B for the bacterial two-hybrid assay data for those P. aeruginosa target 
















Table 6: Genes of interest that were inputted into the bacterial two-hybrid assay and 
individually tested for interaction with each RNAP fragment in the E. coli RNAP 
coreome library. The function for each protein and the percentage of homology to E. coli 








Protein Function % Identity Summary of RNAP 
fragment 
interactions found 
in this study 
algQ 
(control) 
160 Alginate regulatory 
protein. Activated in 
conditions similar to 




α 2-235 R45A & σ 
528-613 D581G 
atpD 458 ADP to ATP synthase in 
the presence of a proton 
gradient across the 
membrane. Catalytic sites 
primarily in the β-chain. 
82 None determined  
clpA 758 ATP-binding protease 
component 
75 β 829-930 & β 831-
1059 
clpB 854 Part of a stress-induced 
multi-chaperone system 
involved in the recovery 
of cell from heat-induced 
damage. DnaK, DnaJ, and 
GrpE are also proteins 
involved. 
76 None determined 
dppF 323 Dipeptide ABC 
transporter ATP-binding 
protein 
71 β' 114-190 & β 1137-
1226 
gcvP 958 Glycine dehydrogenase. 
The glycine cleavage 
system catalyzes the 
degradation of glycine.  
74 None determined 
Lon 798 ATP-dependent serine 
protease that mediates the 
selective degradation of 
mutant and abnormal 
proteins as well as certain 
short-lived regulatory 
proteins. Required for 
cellular homeostasis and 
for survival from DNA 
damage and 
developmental changes 
induced by stress. 









73 β' 248-328 & β' 264-
308 
pstB 277 Part of the ABC 
transporter complex 
PstSACB involved in 
phosphate import. 
Responsible for energy 
coupling to the transport 
system. 
80 None determined 
pyrG 542 CTP synthase. Catalyzes 
the ATP-dependent 
amination of UTP to CTP 
with either L-glutamine or 
ammonia as the source of 
nitrogen. Regulates 
intracellular CTP levels 
through interactions with 
the four ribonucleotide 
triphosphates. 
75 None determined 
rhlE 639 DEAD-box RNA helicase 
involved in ribosome 
assembly. Has RNA-
dependent ATPase 
activity and unwinds 
double-stranded RNA. 
73 α 2-235 R45A 
sdhA 590 Succinate dehydrogenase 
(A subunit). This protein 
is involved in step 1 of the 
subpathway that 
synthesizes fumarate from 
succinate (bacterial route). 






5-' diphosphate) is a 
mediator of the stringent 
response that coordinates 
a variety of cellular 
activities in response to 
changes in nutritional 
abundance. 
73 None determined 
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sutA  105 Transcription factor 
expressed during slow 
growth. Causes 
widespread changes in 
gene expression, and plays 
a direct role in the 
regulation of genes 
encoding ribosomal 
components. Associates 
with chromosomal DNA 
through interaction with 
RNA polymerase. 
Contributes to biofilm 
formation and secondary 
metabolite production. 
Important during 





α 2-235 R45A 
Tig 436 Trigger factor. Involved in 
protein export. Acts as a 
chaperone by maintaining 
the newly synthesized 
protein in an open 
conformation. Functions 
as a peptidyl-prolyl cis-
trans isomerase. 
76 β' 735-790 & β 450-
530 
tsaD 341 O-sialoglycoprotein 
endopeptidase. Required 
for the formation of a 
threonylcarbamoyl group 
on adenosine at position 
37 (t6A37) in tRNAs that 
read codons beginning 
with adenine and plays a 
direct catalytic role in this 
reaction. 
72 α 2-235 R45A 
 
P. aeruginosa ClpA Interacts with RNAP β-flap, β 829-930 and β 831-1059  
Caseinolytic proteases (Clp) is responsible for ATP-dependent degradation of 
cytosolic proteins that are responsible for recognition, unfolding and cleavage of 
substrate proteins into large peptides (Chandu & Nandi, 2004). Clps are barrel-shaped 
ATP-dependent proteases consisting of two domains. One is a catalytic domain and the 
other is regulatory domain. Clp regulators belong to the Clp/Hsp100 family of ATPases, 
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Clp A, B, X and Y (HslU), and are structurally and functionally different. ClpA and ClpB 
have two nucleotide binding domains. ClpB entirely acts as a chaperone protein whereas 
ClpA and ClpX function as chaperones and also bind to ClpP to form the ATP-dependent 
proteases ClpAP or ClpXP (Schirmer et al., 1996).  
The α-ClpA fusion protein activated transcription from the test promoter in the 
presence of pAcI-β 829-930 and had a ~2.5-fold increase in β-galactosidase activity 
compared to α-ClpA + λcI control. α-ClpA fusion protein activated transcription from the 
test promoter in the presence of pAcI-β 831-1059 and had a ~3-fold increase in β-
galactosidase activity compared to α-ClpA + λcI control (Figure 9). Within region β 829-
930 of the E. coli RNAP there was a 93% similarity in the corresponding RNAP region 
of P. aeruginosa. Within region β 831-1059 of the E. coli RNAP there was an 82% 
similarity in the corresponding RNAP region of P. aeruginosa (Table 2). These two 
regions are overlapping fragments of RNAP. These resulted indicated that α-ClpA 
interacted with pAcI-β 829-930 and pAcI-β 831-1059 of the RNAP coreome which 
corresponds to the β-flap domains of RNAP (Schirmer et al., 1996).  
The β-flap domain has multiple roles in enhancer-dependent transcription. 
Remarkably, it also appears to have different functions in enhancer-dependent and 
independent transcription  (Wigneshweraraj et al., 2003). β-flap is also known to bind to 
sigma factors, specifically σ70 R2 and R4 that make simultaneous contact with promoter 
elements. The interaction is required for sequence-specific interaction with the promoter -
10 and a -35 element. It is possible that ClpA binds to RNAP as a chaperone or has some 
role in RNAP-nucleotide interactions; however more investigation is needed to elucidate 
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the role of ClpA-RNAP interaction. ClpA could also play a role in taking damaged or old 
RNAP molecules to the ClpP protease for degradation.  
 
Figure 9: RNAP coreome screen displaying ClpA interactions with RNAP-β 829-
930 & β 831-1059. Diagram shows β-galactosidase transcription activation of a 
bacterial two-hybrid assay. This assay depicts two interactions of an α-fusion of 
P. aeruginosa ClpA with cI-fusion of the E. coli RNAP coreome. The dashed line 
indicates the average background level of β-galactosidase activity. pBRα and 
pACλCI plasmids directed the synthesis of fusion proteins under the control of 
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain 
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase 
activity. β-galactosidase activity is expressed in Miller units indicated on the y-
axis. The x-axis indicates the individual E. coli RNAP coreome fragments being 
expressed in the reporter strain. 
 
P. aeruginosa DppF Interacts with RNAP β’ clamp (β' 114-190) and β 1137-1226  
DppF is a dipeptide inner membrane ATP-binding cassette transporter 
(DppBCDF). Heme is a major iron source and the uptake through E. coli  K12 requires a 
permease made up of DppBCDF (the dipeptide inner membrane transporter) as the ABC 
transporter and either MppA (L-alanyl -ɤ-D-glutamyl-meso-diaminopimelate binding 
protein) or DppA (the dipeptide periplasmic protein) as the soluble periplasmic substrate-
binding protein (PBP) (Létoffé, Delepelaire, & Wandersman, 2006). 
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α-DppF fusion protein activated transcription from the test promoter in the 
presence of pAcI-β' 114-190 and had a ~5-fold increase in β-galactosidase activity 
compared to α-DppF+ λcI control. α-DppF fusion protein activated transcription from the 
test promoter in the presence of pAcI-β 1137-1226 and had a ~4.5-fold increase in β-
galactosidase activity compared to α-DppF+ λcI control (Figure 10). Within region β' 
114-190 of the E. coli RNAP there was a 92% similarity in the corresponding RNAP 
region of P. aeruginosa. Within region β 1137-1226 of the E. coli RNAP there was a 
85% similarity in the corresponding RNAP region of P. aeruginosa (Table 2). These 
results indicated that α-DppF interacted with pAcI-β' 114-190 and pAcI-β 1137-1226 of 
the RNAP coreome. The β’ 114-190 piece of the RNAP coreome is the N-terminal 
domain and is part of the β’ clamp. Studies have found that σ70 adjacent to σ2 called the 
non-conserved region (σ70 NCR) and β’ antagonize the σ2/β′ coiled-coil interaction. 
Specifically, σ70 NCR/β’ interaction facilitates promoter escape and hinders early 
elongation pausing (Leibman & Hochschild, 2007). Unfortunately, not much is known 
about the function of the β 1137-1226 part of the β subunit of RNAP.  
DppF interaction with RNAP is odd. One possibility is that the cytoplasmic side 
of DppF might contain a domain similar to a domain found in other proteins that interact 
with RNAP. It is interesting to note that both ClpA and DppF have ATPase domains. It is 
possible that RNAP might have binding affinity for ATPase domains. If RNAP is 
interacting with these proteins via their ATPase domains making ClpA/DppF α-fusions 
that lack ATPase domains could be used in the bacterial two-hybrid assay. If RNAP is 
interacting with these proteins via their ATPase domains, then ATPase mutants would be 




Figure 10: RNAP coreome screen displays DppF interactions with RNAP-β’ 114-
190 and β 1137-1226. Diagram shows β-galactosidase transcription activation of a 
bacterial two-hybrid assay. This assay depicts two interactions of an α-fusion of 
P. aeruginosa DppF with cI-fusion of the E. coli RNAP coreome. The dashed line 
indicates the average background level of β-galactosidase activity. pBRα and 
pACλcI plasmids directed the synthesis of fusion proteins under the control of 
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain 
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase 
activity. β-galactosidase activity is expressed in Miller units indicated on the y-
axis. The x-axis indicates the individual E. coli RNAP coreome fragments being 
expressed in the reporter strain. 
 
P. aeruginosa Tig Interacts with RNAP β' 735-790 and β 450-530  
Molecular chaperones support protein folding in all living organisms. Chaperones 
have various cellular roles including assisting in de novo folding, refolding of stress-
denatured or aggregated proteins, assembly of oligomeric proteins, protein transport and 
proteolytic degradation. Chaperone proteins can be constitutively expressed whereas 
others are stress-induced. The trigger factor in E. coli is the only ribosome-associated 
chaperone known in bacteria. Trigger factor is constitutively expressed and is an 
abundant cytosolic protein that exists in a two- to three-fold molar excess relative to 
ribosomes (Hoffmann et al., 2010). Trigger factor cooperates with two ATP-dependent 
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chaperones, DnaK and GroEL, in de novo folding. Deletion of trigger factor encoding tig 
has no effects on protein aggregation or obvious growth phenotype and is likely 
compensated by enhanced action of DnaK and GroEL. However, in the absence of DnaK, 
trigger factor become essential at certain growth conditions like high temperature stress. 
Cells lacking dnaK are viable at intermediate growth temperatures, deletion of tig and 
dnaK leads to lethality in cells grown above ~30°C (Hoffmann et al., 2010). 
Trigger factor protein is 48kDa and consists of three domains (Figure 11). The 
PPIase domain, the C-terminal domain and the N-terminal domain. The middle domain of 
trigger factor protein has catalytic activity as a peptidyl-prolyl cis/trans isomerase 
(PPIase). The C-terminal domain constitutes nearly half of the molecule and represents 
the main chaperone module of trigger factor. The N-terminal domain is structurally 
related to parts of the bacterial chaperone Hsp33, but carries an additional helix-loop-
helix element and has ribosome-binding chaperone activity. (Hoffmann et al., 2010).  
 
 




The α-Tig fusion protein activated transcription from the test promoter in the 
presence of pAcI-β' 735-790 and had an ~8-fold increase in β-galactosidase activity 
compared to the α-Tig + λcI control. α-Tig fusion protein activated transcription from the 
test promoter in the presence of pAcI-β 450-530 and had a ~12-fold increase in β-
galactosidase activity compared to α-Tig + λcI control (Figure 12). Within region β' 735-
790 of the E. coli RNAP there was a 100% similarity in the corresponding RNAP region 
of P. aeruginosa. Within region β 450-530 of the E. coli RNAP there was a 92% 
similarity in the corresponding RNAP region of P. aeruginosa. These results indicate that 
Tig interacted with β' 735-790 and β 450-530 of RNAP. Not much is known about the 
function of these pieces of RNAP. However, work performed by Padraig Deighan 
(Personal Communication) demonstrated that Tig in E. coli interacted with β 450-530, 
one of the same pieces that P. aeruginosa Tig interacted with (Figure 13). Tig has known 
chaperone activity on large protein complexes like ribosomes. Currently, no evidence has 
been published indicating Tig has chaperone activity on RNAP.  It could be possible that 
Tig contacts β and β’ subunits of RNAP and aids in RNAP protein folding. Additional 
experiments would be required to determine if Tig has chaperone activity on RNAP 





Figure 12: RNAP coreome screen displays P. aeruginosa Tig interactions with 
RNAP-β’735-790 & β 450-530. Diagram shows β-galactosidase transcription 
activation of a bacterial two-hybrid assay. This assay depicts two interactions of 
an α-fusion of P. aeruginosa Tig with cI-fusion of the E. coli RNAP coreome. 
The dashed line indicates the average background level of β-galactosidase 
activity. pBRα and pACλcI plasmids directed the synthesis of fusion proteins 
under the control of IPTG-inducible promoters. The co-transformed FW102 OL2-
62 reporter strain was grown in the presence of 20 µM IPTG and then assayed for 
β-galactosidase activity. β-galactosidase activity is expressed in Miller units 
indicated on the y-axis. The x-axis indicates the individual E. coli RNAP coreome 










Figure 13: RNAP coreome screen displays E. coli Tig interactions with RNAP- β 
450-530 and β 650-950. Diagram shows β-galactosidase transcription activation 
of a bacterial two-hybrid assay. This assay depicts two interactions of an α-fusion 
of E. coli Tig with cI-fusion of the E. coli RNAP coreome. The dashed line 
indicates the average background level of β-galactosidase activity. pBRα and 
pACλcI plasmids directed the synthesis of fusion proteins under the control of 
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain 
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase 
activity. β-galactosidase activity is expressed in Miller units indicated on the y-
axis. The x-axis indicates the individual E. coli RNAP coreome fragments being 
expressed in the reporter strain. Work performed by Padraig Deighan. 
 
Studying the Strength of Interaction of Target P. aeruginosa proteins with RNAP  
 
Additional bacterial two-hybrid experiments were performed with various 
concentrations of IPTG. Results from these experiments can increase the understanding 
of the strength of interaction between the P. aeruginosa proteins with pieces of the E. coli 
RNAP coreome. Both the target P. aeruginosa proteins and the E. coli RNAP coreome 
fragments are being expressed from IPTG inducible promoters. Adding increasing 
amounts of IPTG would be predicted to cause increasing expression of the fusions 
proteins in the bacterial two-hybrid assay. Increasing the expression of the interacting 
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proteins should drive increased expression of β-galactosidase from the lacZ test promoter, 
resulting in increasing Miller units as the amount of IPTG is increased. 
ClpA Interaction with β-829-930 
To study the strength of the interaction, α-ClpA was tested against the previously 
shown two interacting pieces (β 829-930 and β 831-1059) of the RNAP coreome with 
various concentrations of IPTG (Figure 14). α-ClpA + pAcI-β 829-930 had a background 
value of 296 Miller units in the absence of IPTG, 624 Miller units when induced with 2 
μM IPTG, 822 Miller units when induced with 10 μM IPTG, and 652 Miller units when 
induced with 20 μM IPTG.   
α-ClpA + pAcI-β 829-930 increased to 822 Miller units at 10 μM IPTG and then 
decreased to 652 Miller units at 20 μM IPTG. A decrease in Miller units could be due to 
the overexpression of these proteins in the cell that consume cellular resources that might 
be needed for normal transcription/translation. Another possibility is that overexpressing 
proteins that are interacting with RNAP could disrupt the normal function of RNAP in 
the cell and disrupt normal transcription.  
The negative control pBRα-ClpA + pAcI had a background value of 239 Miller 
units in the absence of IPTG, 279 Miller Units when induced with 2 μM IPTG, 264 
Miller units when induced with 10 μM IPTG, and 154 Miller units when induced with 20 
μM IPTG. The negative control pBRα + pAcI-β 829-930 had a background value of 224 
Miller units in the absence of IPTG, 242 Miller units when induced with 2 μM IPTG, 268 
Miller units when induced with 10 μM IPTG, and 214 Miller units when induced with 20 
μM IPTG. The negative controls have low amounts of Miller units because only one half 
of the protein is being expressed. Within the bacterial two-hybrid assay there is no 
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protein-protein interaction happening so β-galactosidase activity is really low. α-ClpA + 
pAcI-β 829-930 had ~3.5-fold increase in β-galactosidase activity at 10 μM IPTG and a 
~3-fold increase in β-galactosidase activity at 20 μM IPTG compared to the negative 
controls suggesting that we do, in fact, have an interaction.  
Previous studies have demonstrated that σ70 R4 strongly interacts with β-flap of 
RNAP. We used pBRα -σ70 R4 + pAcI-βflap as a positive control and had a background 
value of 546 Miller units in the absence of IPTG, 779 Miller units when induced with 2 
μM IPTG, 1217 Miller units when induced with 10 μM IPTG, and 1350 Miller units 
when induced with 20 μM IPTG. Increasing amounts of IPTG should result in increased 
β-galactosidase production from the lacZ test promoter and this is demonstrated 










Figure 14: Results of bacterial two-hybrid assays performed with the FW102 
OL2-62 E. coli reporter strain transformed with one plasmid that expresses a P. 
aeruginosa α-ClpA fusion protein and a second plasmid expressing the β 829-930 
cI-fusion of the E. coli RNAP coreome. The positive control was the reporter 
strain transformed with a pBRα -σ70 R4 + pAcI-βflap. One negative control was 
the reporter strain transformed with one plasmid expressing the α-ClpA fusion 
protein and a second plasmid expressing λcI. A second negative control was the 
reporter strain transformed with one plasmid expressing just the α protein and a 
second plasmid expressing the β 829-930 cI-fusion. The plasmids directed the 
synthesis of fusion proteins under the control of an IPTG-inducible promoters. 
Reporters strains were grown in the absence or presence of 0, 2, 10, and 20 µM 
IPTG and then assayed for β-galactosidase activity indicated on the x-axis. The 
graph depicts the average of three independent measurements. β-galactosidase 
activity is expressed in Miller units indicated on the y-axis. Error bars indicate 
standard deviation. 
 
ClpA Interaction with β-831-1059 
 α-ClpA + pAcI-β 831-1059 had a background value of 517 Miller units in the 
absence of IPTG 579 Miller Units when induced with 2 μM IPTG, 970 Miller units when 
induced with 10 μM IPTG, and 960 Miller Units when induced with 20 μM IPTG (Figure 
15). Increasing amounts of IPTG should result in increased β-galactosidase production 
from the lacZ test promoter. α-ClpA + pAcI-β 831-1059 increased to 970 Miller units at 
10 μM IPTG and then decreased to 960 Miller units at 20 μM IPTG.  
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The negative control pBRα-ClpA + pAcI had a background value of 132 Miller 
units in the absence of IPTG, 200 Miller units when induced with 2 μM IPTG, 159 Miller 
units when induced with 10 μM IPTG, and 130 Miller units when induced with 20 μM 
IPTG. The negative control pBRα + pAcI-β 831-1059 had a background value of 204 
Miller units in the absence of IPTG, 211 Miller units when induced with 2 μM IPTG, 212 
Miller units when induced with 10 μM IPTG, and 181 Miller units when induced with 20 
μM IPTG. The negative controls have low amounts β-galactosidase activity because only 
one half of the interacting protein pairs are being expressed. In this situation in the 
bacterial two-hybrid assay there is no protein-protein interaction happening so β-
galactosidase activity is really low. α-ClpA + pAcI-β 831-1059 had ~3-fold increase in β-
galactosidase activity at 10 μM and 20 μM IPTG compared to the negative controls 
suggesting that we do, in fact, have an interaction.  
pBRα-σ70 R4 + pAcI-βflap was used as a positive control and had a background 
value of 546 Miller units in the absence of IPTG, 779 Miller units when induced with 2 
μM IPTG, 1217 Miller units when induced with 10 μM IPTG, and 1350 Miller units 
when induced with 20 μM IPTG. Increasing amounts of IPTG should result in increased 
β-galactosidase production from the lacZ test promoter and the positive control 





Figure 15: Results of β-galactosidase assays performed with FW102 OL2-62 E. 
coli reporter strain transformed with one plasmid that expresses an α-ClpA fusion 
protein and with a second plasmid expressing pAcI-β 831-1059 cI-fusion of the E. 
coli RNAP coreome. The positive control was the reporter strain transformed with 
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-ClpA fusion protein and a second 
plasmid expressing λcI. A second negative control was the reporter strain 
transformed with one plasmid expressing just the α protein and a second plasmid 
expressing the β 831-1059 cI-fusion. The plasmids directed the synthesis of 
fusion proteins under the control of an IPTG-inducible promoters. Reporters 
strains were grown in the absence or presence of 0, 2, 10 and 20 µM IPTG and 
then assayed for β-galactosidase activity indicated on the x-axis. The graph 
depicts the average of three independent measurements. β-galactosidase activity is 
expressed in Miller units indicated on the y-axis. Error bars indicate standard 
deviation. 
 
DppF Interaction with β' 114-190 
To study the strength of the interaction, α-DppF was tested against the previously 
shown two interacting pieces of the RNAP coreome (β' 114-190 and β' 1137-1226) with 
various concentrations of IPTG (Figure 16). α-DppF + pAcI-β' 114-190 had a 
background value of 357 Miller units in the absence of IPTG, 843 Miller units when 
induced with 2 μM IPTG, 1017 Miller units when induced with 10 μM IPTG, and 1564 
Miller units when induced with 20 μM IPTG. Increasing amounts of IPTG should result 
in increased β-galactosidase production from the lacZ test promoter.  
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The negative control pBRα-DppF + pAcI had a background value of 217 Miller 
units in the absence of IPTG, 240 Miller units when induced with 2 μM IPTG, 394 Miller 
units when induced with 10 μM IPTG, and 306 Miller units when induced with 20 μM 
IPTG. The negative control pBRα + pAcI-β' 114-190 had a background value of 202 
Miller units in the absence of IPTG, 189 Miller units when induced with 2 μM IPTG, 160 
Miller units when induced with 10 μM IPTG, and 121 Miller units when induced with 20 
μM IPTG. The negative controls have low amounts β-galactosidase activity because only 
one half of the interacting protein pairs are being expressed. In this situation in the 
bacterial two-hybrid assay there is no protein-protein interaction happening so β-
galactosidase activity is really low. DppF + pAcI-β' 114-190 had ~3-fold increase in β-
galactosidase activity at 10 μM IPTG and a ~5-fold increase in β-galactosidase activity at 
20 μM IPTG compared to the negative controls suggesting that there is an interaction. 
 pBRα -σ70 R4 + pAcI-βflap was used as a positive control and had a background 
value of 447 Miller units in the absence of IPTG, 799 Miller units when induced with 2 
μM IPTG, 646 Miller units when induced with 10 μM IPTG, and 767 Miller units when 




Figure 16: Results of β-galactosidase assays performed with FW102 OL2-62 E. 
coli reporter strain transformed with one plasmid that expresses an α- α-DppF 
fusion protein and with a second plasmid expressing pAcI-β' 114-190 cI-fusion of 
the E. coli RNAP coreome. The positive control was the reporter strain 
transformed with plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was 
the reporter strain transformed with one plasmid expressing the α-DppF fusion 
protein and a second plasmid expressing λcI. A second negative control was the 
reporter strain transformed with one plasmid expressing just the α protein and a 
second plasmid expressing the β’ 114-190 cI-fusion. The plasmids directed the 
synthesis of fusion proteins under the control of an IPTG-inducible promoters. 
Reporters strains were grown in the absence or presence of 0, 2, 10 and 20 µM 
IPTG and then assayed for β-galactosidase activity indicated on the x-axis. The 
graph depicts the average of three independent measurements. β-galactosidase 
activity is expressed in Miller units indicated on the y-axis. Error bars indicate 
standard deviation. 
 
DppF Interaction with β’ 1137-1226 
α-DppF + pAcI-β' 1137-1226 had a background value of 368 Miller units in the 
absence of IPTG, 1036 Miller units when induced with 2 μM IPTG, 1127 Miller units 
when induced with 10 μM IPTG, and 1063 Miller units when induced with 20 μM IPTG 
(Figure 17). Increasing amounts of IPTG should result in increased β-galactosidase 
production from the lacZ test promoter.  
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The negative control pBRα-DppF + pAcI had a background value of 124 Miller 
units in the absence of IPTG, 128 Miller units when induced with 2 μM IPTG, 290 Miller 
units when induced with 10 μM IPTG, and 256 Miller units when induced with 20 μM 
IPTG. The negative control pBRα + β' 1137-1226 had a background value of 86 Miller 
units in the absence of IPTG, 136 Miller units when induced with 2 μM IPTG, 124 Miller 
units when induced with 10 μM IPTG, and 98 Miller units when induced with 20 μM 
IPTG. The negative controls have low amounts β-galactosidase activity because only one 
half of the interacting protein pairs are being expressed. In this situation in the bacterial 
two-hybrid assay there is no protein-protein interaction happening so β-galactosidase 
activity is really low. α-DppF + pAcI-β' 1137-1226 had ~4-fold increase in β-
galactosidase activity at 10 μM and 20 μM IPTG compared to the negative controls 
suggesting that there is an interaction. 
pBRα -σ70 R4 + pAcI-βflap was used as a positive control and had a background 
value of 819 Miller units in the absence of IPTG, 760 Miller units when induced with 2 
μM IPTG, 798 Miller units when induced with 10 μM IPTG, and 1058 Miller units when 






Figure 17: Results of β-galactosidase assays performed with FW102 OL2-62 E. 
coli reporter strain transformed with one plasmid that expresses an α-DppF fusion 
protein and with a second plasmid expressing pAcI-β 1137-1226 cI-fusion of the 
E. coli RNAP coreome. The positive control was the reporter strain transformed 
with plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter 
strain transformed with one plasmid expressing the α-DppF fusion protein and a 
second plasmid expressing λcI. A second negative control was the reporter strain 
transformed with one plasmid expressing just the α protein and a second plasmid 
expressing the β 1137-1226 cI-fusion. The plasmids directed the synthesis of 
fusion proteins under the control of an IPTG-inducible promoters. Reporters 
strains were grown in the absence or presence of 0, 2, 10 and 20 µM IPTG and 
then assayed for β-galactosidase activity indicated on the x-axis. The graph 
depicts the average of three independent measurements. β-galactosidase activity is 
expressed in Miller units indicated on the y-axis. Error bars indicate standard 
deviation. 
 
Tig Interaction with β' 735-790 
α-Tig + pAcI -β' 735-790 had a background value of 619 Miller units in the 
absence of IPTG, 1250 Miller units when induced with 2 μM IPTG, 400 Miller units 
when induced with 10 μM IPTG, and 547 Miller units when induced with 20 μM IPTG 
(Figure 18). Increasing amounts of IPTG should result in increased β-galactosidase 
production from the lacZ test promoter. 
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The negative control pBRα-Tig + pAcI had a background value of 57 Miller units 
in the absence of IPTG, 177 Miller units when induced with 2 μM IPTG, 218 Miller units 
when induced with 10 μM IPTG, and 211 Miller units when induced with 20 μM IPTG. 
The negative control pBRα + β' 735-790 had a background value of 123 Miller units in 
the absence of IPTG, 186 Miller units when induced with 2 μM IPTG, 169 Miller units 
when induced with 10 μM IPTG, and 156 Miller units when induced with 20 μM IPTG. 
The negative controls have low amounts β-galactosidase activity because only one half of 
the interacting protein pairs are being expressed. In this situation in the bacterial two-
hybrid assay there is no protein-protein interaction happening so β-galactosidase activity 
is really low. α-Tig + pAcI -β' 735-790 had ~5-fold increase in β-galactosidase activity at 
2 μM IPTG compared to the negative controls suggesting that there is an interaction. 
pBRα -σ70 R4 + pAcI-βflap was used as a positive control and had a background 
value of 911 Miller units in the absence of IPTG, 1064 Miller units when induced with 2 
μM IPTG, 901 Miller units when induced with 10 μM IPTG, and 933 Miller units when 
induced with 20 μM IPTG. As depicted in Figure 18 there is a dramatic decrease in β-
galactosidase activity in α-Tig + pAcI- β' 735-790. Overexpression of the fusion protein 
could have toxic effects on the cell. The fusion protein could be interacting with other 
proteins in the cell and disrupt normal protein-protein interactions. If the fusion protein is 
interacting with RNAP, overexpression of the target protein could affect normal 




Figure 18: Results of β-galactosidase assays performed with FW102 OL2-62 E. 
coli reporter strain transformed with one plasmid that expresses an α-Tig fusion 
protein and with a second plasmid expressing pAcI-β' 735-790 cI-fusion of the E. 
coli RNAP coreome. The positive control was the reporter strain transformed with 
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-Tig fusion protein and a second 
plasmid expressing λcI. A second negative control was the reporter strain 
transformed with one plasmid expressing just the α protein and a second plasmid 
expressing the β' 735-790 cI-fusion. The plasmids directed the synthesis of fusion 
proteins under the control of an IPTG-inducible promoters. Reporters strains were 
grown in the absence or presence of 0, 2, 10 and 20 µM IPTG and then assayed 
for β-galactosidase activity indicated on the x-axis. The graph depicts the average 
of three independent measurements. β-galactosidase activity is expressed in Miller 
units indicated on the y-axis. Error bars indicate standard deviation. 
  
Tig Interaction with β 450-530 
α-Tig + pAcI –β 450-530 had a background value of 360 Miller units in the 
absence of IPTG, 901 Miller units when induced with 2 μM IPTG, 617 Miller units when 
induced with 10 μM IPTG, and 1326 Miller units when induced with 20 μM IPTG 
(Figure 19). Increasing amounts of IPTG should result in increased β-galactosidase 
production from the lacZ test promoter. 
The negative control pBRα-Tig + pAcI had a background value of 190 Miller 
units in the absence of IPTG, 258 Miller units when induced with 2 μM IPTG, 334 Miller 
units when induced with 10 μM IPTG, and 241 Miller units when induced with 20 μM 
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IPTG. The negative control pBRα + pAcI –β 450-530 had a background value of 188 
Miller in the absence of IPTG, 187 Miller units when induced with 2 μM IPTG, 185 
Miller units when induced with 10 μM IPTG, and 171 Miller units when induced with 20 
μM IPTG. The negative controls have low amounts β-galactosidase activity because only 
one half of the interacting protein pairs are being expressed. In this situation in the 
bacterial two-hybrid assay there is no protein-protein interaction happening so β-
galactosidase activity is really low. α-Tig + pAcI –β 450-530 had ~3-fold increase in β-
galactosidase activity at 2 μM IPTG and a ~5-fold increase in β-galactosidase activity 
compared to the negative controls suggesting that there is an interaction. 
 pBRα -σ70 R4 + pAcI-βflap was used as a positive control and had a background 
value of 627 Miller units in the absence of 0 μM IPTG, 1228 Miller units when induced 
with 2 μM IPTG, 1096 Miller units when induced with 10μM IPTG, and 862 Miller units 








Figure 19: Results of β-galactosidase assays performed with FW102 OL2-62 E. 
coli reporter strain transformed with one plasmid that expresses an α-Tig fusion 
protein and with a second plasmid expressing pAcI-β 450-530 cI-fusion of the E. 
coli RNAP coreome. The positive control was the reporter strain transformed with 
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-Tig fusion protein and a second 
plasmid expressing λcI. A second negative control was the reporter strain 
transformed with one plasmid expressing just the α protein and a second plasmid 
expressing the β 450-530 cI-fusion. The plasmids directed the synthesis of fusion 
proteins under the control of an IPTG-inducible promoters. Reporters strains were 
grown in the absence or presence of 0, 2, 10 and 20 µM IPTG and then assayed 
for β-galactosidase activity indicated on the x-axis. The graph depicts the average 
of three independent measurements. β-galactosidase activity is expressed in Miller 
units indicated on the y-axis. Error bars indicate standard deviation. 
 
Validating Protein-Protein Interactions by Reversing the Order of the Fusion 
Proteins Expressed by the Bait and Prey plasmids 
If two proteins are really interacting in the bacterial two-hybrid assay, in principle 
it should not matter which protein is fused to cI, and which protein is fused to the α-
subunit of RNAP. Previously, RNAP interactions were shown with α-fusions of ClpA, 
DppF, and Tig. Additional plasmid constructs were made that expressed cI-fusions of P. 
aeruginosa ClpA, DppF, and Tig. These cI fusion proteins were then tested for 
interactions with their appropriate targets on RNAP, this time fused to the α-subunit of 
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RNAP. We predicted that the protein-protein interactions would remain the same 
regardless of what the protein is fused too.  
      The assays were performed as before. The reporter strain was co-transformed with a 
bait plasmid and a prey plasmid. The co-transformed reporter strain was then grown in 
the presence of increasing amounts of IPTG (0, 10 and 20 µM). As the amount of IPTG 
increases, this would lead to the increase in expression of the interacting target proteins 
followed by a corresponding increase in β-galactosidase expression from the test 
promoter.  
ClpA Interactions with pBRα-β 829-930 and pBRα-β 831-1059 
When the reporter strain was co-transformed with pAcI-ClpA + pBRα-β 829-930 
or pAcI-ClpA + pBRα-β 831-1059, the β-galactosidase activity detected was similar to 
the negative controls. pAcI-ClpA + pBRα-β 829-930 and had a background value of 152 
Miller units in the absence of IPTG, 107 Miller units when induced with 10 μM IPTG, 
and 102 Miller units when induced with 20 μM IPTG. pAcI-ClpA + pBRα-β 831-1059 
had a background value of 267 Miller units in the absence of IPTG, 258 Miller units 
when induced with 10μ M IPTG, and 307 Miller units when induced with 20 μM IPTG.  
The negative control was the reporter strain co-transformed with pAcI-ClpA + 
pBRα and it had a background value of 143 Miller units in the absence of IPTG, 59 
Miller units when induced with 10 μM IPTG, and 72 Miller units when induced with 20 
μM IPTG. pBRα-β 829-930 + pAcI had a background value of 219 Miller units in the 
absence of IPTG, 290 Miller units when induced with 10 μM IPTG, and 109 Miller units 
when induced with 20 μM IPTG. pBRα-β 831-1059 + pAcI had a background value of 
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310 Miller units in the absence of IPTG, 387 Miller units when induced with 10 μM 
IPTG, and 275 Miller units when induced with 20 μM IPTG.  
From this data, it was interpreted that the cI-ClpA fusion protein had no 
significant interaction with the α-β 829-930 or α-β 831-1059 fusion proteins. The assay 
was clearly functioning because the positive control strain co-transformed with pBRα -
σ70 R4 + pAcI-βflap had a background value of 255 Miller units in the absence of IPTG, 
1920 Miller units when induced with 10 μM IPTG, and 1043 Miller units when induced 
with 20 μM IPTG (Figure 20). While it was surprising that there was no significant 
interaction between ClpA and β 829-930 or ClpA and β 831-1059 when the fusion 
protein order was in the reverse order, there is a potential explanation for this. ClpA is a 
large protein comprised of 754 amino acids. A reasonable explanation is that ClpA fused 
to the C-terminus of λcI results in steric hindrance, disrupting the dimerization of λcI that 
is required for the N-terminus to bind to DNA (Kedzierska et al., 2007). Larger protein 
fusions can be made to the α-subunit of RNAP because it contains a longer flexible 








Figure 20: Results of β-galactosidase assays performed with FW102 OL2-62 E. 
coli reporter strain transformed with one plasmid that expresses an α-β 829-930 
fusion protein with a second plasmid expressing pAcI-ClpA cI-fusion of the E. 
coli RNAP coreome. Another plasmid expressed α- β 831-1059 fusion protein 
with a second plasmid expressing pAcI-ClpA cI-fusion of the E. coli RNAP 
coreome. The positive control was the reporter strain transformed with plasmid 
pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-β 829-930 fusion protein and a 
second plasmid expressing λcI. A second negative control was the reporter strain 
transformed with one plasmid expressing α- β 831-1059 fusion protein and a 
second plasmid expressing λcI. A third negative control was the reporter strain 
transformed with one plasmid expressing just the α protein and a second plasmid 
expressing the ClpA cI-fusion. The plasmids directed the synthesis of fusion 
proteins under the control of an IPTG-inducible promoters. Reporters strains were 
grown in the absence or presence of 0, 10 and 20 µM IPTG and then assayed for 
β-galactosidase activity indicated on the x-axis. The graph depicts the average of 
three independent measurements. β-galactosidase activity is expressed in Miller 
units indicated on the y-axis. Error bars indicate standard deviation. 
  
 
DppF Interactions with β' 114-190 and β 1137-1226 
pAcI-DppF + pBRα-β' 114-190 had a background value of 769 Miller units in the 
absence of IPTG, 1180 Miller units when induced with 10 μM IPTG, and 674 Miller 
units when induced with 20 μM IPTG. pAcI-DppF + pBR α-β 1137-1226 had a 
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background value of 175 Miller units in the absence of IPTG, 137 Miller units when 
induced with 10 μM IPTG, and 128 Miller units when induced with 20 μM IPTG. The 
negative control was the reporter strain co-transformed with pAcI-DppF + pBRα and had 
a background value of 155 Miller units in the absence of IPTG, 121 Miller units when 
induced with 10 μM IPTG, and 100 Miller units when induced with 20 μM IPTG. pBRα-
β' 114-190 + pAcI had a background value of 313 Miller units in the absence of IPTG, 
344 Miller units when induced with 10 μM IPTG, and 240 Miller units when induced 
with 20 μM IPTG. pBRα-β 1137-1226 + pAcI had a background value of 131 Miller 
units in the absence of IPTG, 207 Miller units when induced with 10 μM IPTG, and 165 
Miller units when induced with 20 μM IPTG.  
From this data, it was interpreted that the cI-DppF fusion protein had no 
significant interaction with the α-β 1137-1226 fusion protein (Figure 21). This needs to 
be further investigated. Further experiments in which α-DppF has been mutagenized 
could be used to determine if the interaction with β 1137-1226 is real. DppF did have an 
interaction with β' 114-190 and had a ~4-fold increase in β-galactosidase activity when 
induced with 10 μM IPTG compared to the negative controls. This data suggests that 
there is an interaction between DppF and β' 114-190 protein, but had no significant 
interaction with β 1137-1226. 
The assay was clearly functioning because the positive control strain co-
transformed with pBRα -σ70 R4 + pAcI-βflap had a background value of 2255 Miller 
units in the absence of IPTG, 3525 Miller units when induced with 10 μM IPTG, and 




Figure 21: Results of β-galactosidase assays performed with FW102 OL2-62 E. 
coli reporter strain transformed with one plasmid that expresses an α-β’ 114-190 
fusion protein with a second plasmid expressing pAcI-DppF cI-fusion of the E. 
coli RNAP coreome. Another plasmid expressed α- β’ 1137-1226 fusion protein 
with a second plasmid expressing pAcI-DppF cI-fusion of the E. coli RNAP 
coreome. The positive control was the reporter strain transformed with plasmid 
pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-β’ 114-190 fusion protein and a 
second plasmid expressing λcI. A second negative control was the reporter strain 
transformed with one plasmid expressing α- β’ 1137-1226 fusion protein and a 
second plasmid expressing λcI. A third negative control was the reporter strain 
transformed with one plasmid expressing just the α protein and a second plasmid 
expressing the DppF cI-fusion. The plasmids directed the synthesis of fusion 
proteins under the control of an IPTG-inducible promoters. Reporters strains were 
grown in the absence or presence of 0, 10 and 20 µM IPTG and then assayed for 
β-galactosidase activity indicated on the x-axis. The graph depicts the average of 
three independent measurements. β-galactosidase activity is expressed in Miller 
units indicated on the y-axis. Error bars indicate standard deviation. 
 
Tig Interactions with β’ 735-790 and β 450-530 
cI-Tig + α-β' 735-790 had a background value of 304 Miller units in the absence 
of IPTG, 698 Miller units when induced with 10 μM IPTG, and 542 Miller units when 
induced with 20 μM IPTG. pAcI-Tig + pBR α-β 450-530 had a background value of 174 
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Miller units in the absence of IPTG, 593 Miller units when induced with 10 μM IPTG, 
and 574 Miller units when induced with 20 μM IPTG.  
The negative control was the reporter strain co-transformed with pAcI-Tig + 
pBRα and it had a background value of 42 Miller units in the absence of IPTG, 71 Miller 
units when induced with 10 μM IPTG, and 51 Miller units when induced with 20 μM 
IPTG. pBRα-β' 735-790 + pAcI had a background value of 291 Miller units in the 
absence of IPTG, 291 Miller units when induced with 10 μM IPTG, and 148 Miller units 
when induced with 20 μM IPTG. pBRα-β 450-530 + pAcI had a background value of 141 
Miller units in the absence of IPTG, 141 Miller units when induced with 10 μM IPTG, 
and 190 Miller units when induced with 20 μM IPTG.  
cI-Tig + α-β' 735-790 and cI-Tig + α-β 450-530 had ~2-fold increase in β-
galactosidase activity at 10 and 2 μM IPTG compared to the negative controls. From this 
data, it was interpreted that the cI-Tig fusion protein had a significant interaction with the 
α- β' 735-790 and α-β 450-530 fusion proteins at 10 and 20 μM IPTG. Although only a 2-
fold increase in β-galactosidase activity was detected, this does indicate the interaction is 
real. The assay was clearly functioning because the positive control strain co-transformed 
with pBRα -σ70 R4 + pAcI-βflap had a background value of 1548 Miller units in the 
absence of IPTG, 1661 Miller units when induced with 10 μM IPTG, and 969 Miller 
units when induced with 20 μM IPTG. The decrease in Miller units is likely due to the 
overexpression of these proteins in the cell that consume cellular resources that might be 
needed for normal transcription/translation. Also, overexpressing proteins that are 
interacting with RNAP could disrupt the normal function of RNAP in the cell and disrupt 





Figure 22: Results of β-galactosidase assays performed with FW102 OL2-62 E. 
coli reporter strain transformed with one plasmid that expresses an α-β’ 735-790 
fusion protein with a second plasmid expressing pAcI-Tig cI-fusion of the E. coli 
RNAP coreome. Another plasmid expressed α- β 450-530 fusion protein with a 
second plasmid expressing pAcI-Tig cI-fusion of the E. coli RNAP coreome. The 
positive control was the reporter strain transformed with plasmid pBRα -σ70 R4 + 
pAcI-βflap. One negative control was the reporter strain transformed with one 
plasmid expressing the α-β’ 735-790 fusion protein and a second plasmid 
expressing λcI. A second negative control was the reporter strain transformed 
with one plasmid expressing α- β 450-530 fusion protein and a second plasmid 
expressing λcI. A third negative control was the reporter strain transformed with 
one plasmid expressing just the α protein and a second plasmid expressing the Tig 
cI-fusion. The plasmids directed the synthesis of fusion proteins under the control 
of an IPTG-inducible promoters. Reporters strains were grown in the absence of 
presence of 0, 10 and 20 µM IPTG and then assayed for β-galactosidase activity 
indicated on the x-axis. The graph depicts the average of three independent 
measurements. β-galactosidase activity is expressed in Miller units indicated on 
the y-axis. Error bars indicate standard deviation. 
 
Defining Tig interaction sites with RNAP.   
Domains of α-Tig (1-3) 
Tig was chosen for further investigation because it had the highest interaction out 
of the 3 P. aeruginosa target proteins tested. E. coli Tig also had one of the strongest 
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interactions with RNAP (P. Deighan, Personal Communication and Figure 13). Tig 
interaction with β' 735-790 had an ~8-fold increase in β-galactosidase activity compared 
to the negative controls (Figure 12). Tig interaction with β 450-530 had a ~12-fold 
increase in β-galactosidase activity compared to the negative control (Figure 12). Tig has 
3 structural domains. To individually test each domain, the domains were broken up 
based on the amino acid sequences 1-149 for α-Tig Domain 1, 149-245 for α-Tig Domain 
2, 245-532 for α-Tig Domain 3, 1 – 245 for α-Tig Domain 1+ 2, and 149-432 for α-Tig 
Domain 2+3 (Figure 11). These experiments were performed to further define the site of 
interaction between Tig and RNAP.   
Tig Domain 1 Interactions with β' 735-790 and β 450-530 
When the reporter strain was co-transformed with pBRα-Tig Domain 1+ pAcI-β' 
735-790 or pBRα-Tig Domain 1 + pAcI-β 450-530 the β-galactosidase activity generated 
from the test promoter was comparable to the negative control under all IPTG conditions 
(Figure 24). pBRα-Tig Domain 1+ pAcI-β' 735-790 had a background value of 252 
Miller units in the absence of IPTG, 409 Miller units when induced with 10 μM IPTG, 
and 295 Miller units when induced with 20 μM IPTG. pBRα-Tig Domain 1 + pAcI-β 
450-530 had a background value of 324 Miller units in the absence of IPTG, 273 Miller 
units when induced with 10 μM IPTG, and 161 Miller units when induced with 20 μM 
IPTG. The negative control tested the interaction between Tig Domain 1 and λcI and had 
a background value of 206 Miller units in the absence of IPTG, 315 Miller units when 
induced with 10 μM IPTG, and 187 Miller units when induced with 20 μM IPTG.  
These results suggest that Tig Domain 1 had no significant interaction with RNAP 
β' 735-790 or β 450-530. The assay was functioning because the positive control pBRα-
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σ70 R4 + pAcI-βflap had a background value of 510 Miller units in the absence of IPTG, 
3188 Miller units when induced with 10 μM IPTG, and 1173 Miller units when induced 
with 20 μM IPTG. There is a dramatic decrease in β-galactosidase activity in α-σ70 R4 + 
pAcI-βflap at 20 μM IPTG. Overexpression of the fusion protein could have toxic effects 
on the cell for the previously mentioned reasons.  
 
 
Figure 23: Results of bacterial two-hybrid assays performed with the FW102 OL2-
62 E. coli reporter strain transformed with one plasmid that expresses an α-Tig 
Domain 1 fusion protein and with a second plasmid expressing β' 735-790 or β 
450-530 fused to cI. The positive control was the reporter strain transformed with 
plasmid pBRα -σ 70 R4 + pAcI-βflap. One negative control was the reporter 
strain transformed with one plasmid expressing the α-Tig Domain 1 fusion protein 
and a second plasmid expressing λcI. The plasmids directed the synthesis of 
fusion proteins under the control of an IPTG-inducible promoters. Reporters 
strains were grown in the absence or presence of 0, 10 and 20 µM IPTG and then 
assayed for β-galactosidase activity indicated on the x-axis. The graph depicts the 
average of three independent measurements. β-galactosidase activity is expressed 






Tig Domain 2 Interactions with β' 735-790 and β 450-530 
When the reporter strain was co-transformed with pBRα-Tig Domain 2 + pAcI-β' 
735-790 or pBRα-Tig Domain 2 + pAcI-β 450-530 the β-galactosidase activity generated 
from the test promoter was comparable to the negative control under all IPTG conditions 
(Figure 24). pBRα-Tig Domain 2 + pAcI-β' 735-790 had a background value of 282 
Miller units in the absence of IPTG, 451 Miller units when induced with 10 μM IPTG, 
and 458 Miller units when induced with 20 μM IPTG. pBRα-Tig Domain 2 + pAcI-β 
450-530 had a background value of 267 Miller units in the absence of IPTG, 355 Miller 
units when induced with 10 μM IPTG, and 294 Miller units when induced with 20 μM 
IPTG.  
The negative control tested the interaction between Tig Domain 2 and λcI and had 
a background value of 276 Miller units in the absence of IPTG, 399 Miller units when 
induced with 10 μM IPTG, and 271 Miller units when induced with 20 μM IPTG. These 
results suggest that Tig Domain 2 had no significant interaction with RNAP β' 735-790 or 
β 450-530. The assay was functioning because the positive control pBRα-σ70 R4 + pAcI-
βflap had a background value of 536 Miller units in the absence of IPTG, 1370 Miller 
units when induced with 10 μM IPTG, and 1764 Miller units when induced with 20 μM 








Figure 24: Results of bacterial two-hybrid assays performed with the FW102 OL2-
62 E. coli reporter strain transformed with one plasmid that expresses an α-Tig 
Domain 2 fusion protein and with a second plasmid expressing β' 735-790 or β 
450-530 fused to cI. The positive control was the reporter strain transformed with 
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-Tig Domain 2 fusion protein and a 
second plasmid expressing λcI. The plasmids directed the synthesis of fusion 
proteins under the control of an IPTG-inducible promoters. Reporters strains were 
grown in the absence or presence of 0, 10 and 20 µM IPTG and then assayed for 
β-galactosidase activity indicated on the x-axis. The graph depicts the average of 
three independent measurements. β-galactosidase activity is expressed in Miller 
units indicated on the y-axis. Error bars indicate standard deviation. 
 
Tig Domain 3 Interactions with β' 735-790 and β 450-530 
When the reporter strain was co-transformed with pBRα-Tig Domain 3+ pAcI-β' 
735-790 or pBRα-Tig Domain 3 + pAcI-β 450-530 the β-galactosidase activity generated 
from the test promoter was comparable to the negative control under all IPTG conditions 
(Figure 25). pBRα-Tig Domain 3+ pAcI-β' 735-790 had a background value of 175 
Miller units in the absence of IPTG, 190 Miller units when induced with 10 μM IPTG, 
and 226 Miller units when induced with 20 μM IPTG. pBRα-Tig Domain 3 + pAcI-β 
450-530 had a background value of 149 Miller units in the absence of IPTG, 130 Miller 
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units when induced with 10 μM IPTG, and 166 Miller units when induced with 20 μM 
IPTG.  
The negative control tested the interaction between Tig Domain 3 and λcI and had 
a background value of 167 Miller units in the absence of IPTG, 205 Miller units when 
induced with 10 μM IPTG, and 159 Miller units when induced with 20 μM IPTG. These 
results suggest that Tig Domain 3 had no significant interaction with RNAP β' 735-790 or 
β 450-530. The assay was functioning because the positive control pBRα-σ70 R4 + pAcI-
βflap had a background value of 1266 Miller units in the absence of IPTG, 3876 Miller 
units when induced with 10 μM IPTG, and 1313 Miller units when induced with 20 μM 
IPTG. There is a dramatic decrease in β-galactosidase activity in α-σ70 R4 + pAcI-βflap at 
20 μM IPTG. Over expression of the fusion protein could have toxic effects on the cell 
for the previously mentioned reasons. Together these results suggest that the Tig 











Figure 25: Results of bacterial two-hybrid assays performed with the FW102 OL2-
62 E. coli reporter strain transformed with one plasmid that expresses an α-Tig 
Domain 3 fusion protein and with a second plasmid expressing β' 735-790 or β 
450-530 fused to cI. The positive control was the reporter strain transformed with 
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-Tig Domain 3 fusion protein and a 
second plasmid expressing λcI. The plasmids directed the synthesis of fusion 
proteins under the control of an IPTG-inducible promoters. Reporters strains were 
grown in the absence or presence of 0, 10 and 20 µM IPTG and then assayed for 
β-galactosidase activity indicated on the x-axis. The graph depicts the average of 
three independent measurements. β-galactosidase activity is expressed in Miller 
units indicated on the y-axis. Error bars indicate standard deviation. 
 
Tig Domains 1+2 interactions with RNAP β' 735-790 and β 450-530 
Since there was no interaction detected between the individual Tig domains and 
RNAP, it could be possible that the Tig interaction site with RNAP spans multiple 
domains. In the following set of experiments Tig domains 1+2 and 2+3 were cloned into 
the pBRα expression vector. Bacterial two-hybrid experiments were then performed with 
Tig domains 1+2 and Tig domains 2+3. When the reporter strain was co-transformed 
with pBRα-Tig Domain 1+2 + pAcI-β' 735-790 or pBRα-Tig Domain 1+2 + pAcI-β 450-
530 the β-galactosidase activity generated from the test promoter was comparable to the 
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negative control under all IPTG conditions (Figure 26). pBRα-Tig Domain 1+2 + pAcI-β' 
735-790 had a background value of 322 Miller units in the absence of IPTG, 468 Miller 
units when induced with 10 μM IPTG, and 333 Miller units when induced with 20 μM 
IPTG. pBRα-Tig Domain 1+2 + pAcI-β 450-530 had a background value of 329 Miller 
units when in the absence of IPTG, 395 Miller units when induced with 10 μM IPTG, and 
257 Miller units when induced with 20 μM IPTG.  
The negative control tested the interaction between Tig Domain 1+2 and λcI and 
had a background value of 298 Miller units in the absence of IPTG, 389 Miller units 
when induced with 10 μM IPTG, and 285 Miller units when induced with 20 μM IPTG. 
These results suggest that Tig Domain 1+2 had no significant interaction with RNAP β' 
735-790 or β 450-530. The assay was functioning because the positive control pBRα-σ70 
R4 + pAcI-βflap had a background value of 437 Miller units in the absence of IPTG, 862 
Miller units when induced with 10 μM IPTG, and 1869 Miller units when induced with 








Figure 26: Results of bacterial two-hybrid assays performed with the FW102 OL2-
62 E. coli reporter strain transformed with one plasmid that expresses an α-Tig 
Domain 1+2 fusion protein and with a second plasmid expressing β' 735-790 or β 
450-530 fused to cI. The positive control was the reporter strain transformed with 
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-Tig Domain 1+2 fusion protein 
and a second plasmid expressing λcI. The plasmids directed the synthesis of 
fusion proteins under the control of an IPTG-inducible promoters. Reporters 
strains were grown in the absence or presence of 0, 10 and 20 µM IPTG and then 
assayed for β-galactosidase activity indicated on the x-axis. The graph depicts the 
average of three independent measurements. β-galactosidase activity is expressed 
in Miller units indicated on the y-axis. Error bars indicate standard deviation. 
 
Tig Domains 2+3 interactions with RNAP β' 735-790 and β 450-530 
 When the reporter strain was co-transformed with pBRα-Tig Domain 2+3 + 
pAcI-β' 735-790 or pBRα-Tig Domain 2+3 + pAcI-β 450-530 the β-galactosidase activity 
generated from the test promoter was comparable to the negative control under all IPTG 
conditions (Figure 27). pBRα-Tig Domain 2+3 + pAcI-β' 735-790 had a background 
value of 232 Miller units in the absence of IPTG, 333 Miller units when induced with 10 
μM IPTG, and 313 Miller units when induced with 2 μM IPTG. pBRα-Tig Domain 2+3 + 
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pAcI-β 450-530 had a background value of 235 Miller units in the absence of IPTG, 226 
Miller units when induced with 10 μM IPTG, and 289 Miller units when induced with 20 
μM IPTG. 
The negative control tested the interaction between Tig Domain 2+3 and λcI and 
had a background value of 431 Miller units in the absence of IPTG, 373 Miller units 
when induced with 10 μM IPTG, and 350 Miller units when induced with 20 μM IPTG. 
These results suggest that Tig Domain 2+3 had no significant interaction with RNAP β' 
735-790 or β 450-530. The assay was functioning because the positive control pBRα-σ70 
R4 + pAcI-βflap had a background value of 832 Miller units in the absence of IPTG, 797 
Miller units when induced with 10 μM IPTG, and 677 Miller units when induced with 20 











Figure 27: Results of bacterial two-hybrid assay performed with the FW102 OL2-
62 E. coli reporter strain transformed with one plasmid that expresses an α-Tig 
Domain 2+3 fusion protein and with a second plasmid expressing β' 735-790 or β 
450-530 fused to cI. The positive control was the reporter strain transformed with 
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain 
transformed with one plasmid expressing the α-Tig Domain 2+3 fusion protein 
and a second plasmid expressing λcI. The plasmids directed the synthesis of 
fusion proteins under the control of an IPTG-inducible promoters. Reporters 
strains were grown in the presence of 0,10 and 20 µM IPTG and then assayed for 
β-galactosidase activity indicated on the x-axis. The graph depicts the average of 
three independent measurements. β-galactosidase activity is expressed in Miller 
units indicated on the y-axis. Error bars indicate standard deviation.  
 
In summary, no single Tig domain was found to interact with β’ 735-790 or β 
450-530 of RNAP. One explanation could be that multiple Tig domains are required for 
the interaction with RNAP. However, in this assay the combinations of Tig domains 1+2 
and 2+3 also did not show interaction with RNAP. The crystal structure of Tig indicates 
it is a highly structured protein (Hoffmann et al., 2010). Without all three domains 









The purpose of this study was to determine if using an E. coli RNAP coreome 
could be used to detect RNAP-interacting proteins in P. aeruginosa. A bacterial two-
hybrid assay was used as a tool to study protein-protein interactions. In summary, we 
found that out of the 16 proteins initially screened, α-ClpA, α-DppF, and α-Tig interacted 
with the E. coli RNAP coreome. α-ClpA interacted with β 829-930 and β 831-1059. α-
DppF interacted with β' 114-190 and β 1137-1226. α-Tig interacted with β' 735-790 and β 
450-530 of the RNAP coreome. These proteins were further investigated to test the 
strength of each interacting protein with various amounts of IPTG.  
Reversing the orientation of the fusion proteins expressed by the bait and prey 
plasmids were also conducted and β-galactosidase assays were performed. We found that 
when the reporter strain was co-transformed with pAcI-ClpA + pBRα-β 829-930 or pAcI-
ClpA + pBRα-β 831-1059, the β-galactosidase activity detected was similar to the 
negative controls. Because ClpA is a large protein we think that ClpA fused to the C 
terminus of λcI results in steric hindrance, disrupting the dimerization of λcI that is 
required for the N terminus to bind to DNA.  
DppF fusion protein had no significant interaction with the α-β 1137-1226 fusion 
protein. cI-DppF did however have an interaction with α-β' 114-190 and had a ~4-fold 
increase in β-galactosidase activity when induced with 10μM IPTG compared to the 
negative controls. This data suggests that there is an interaction between cI-DppF fusion 
protein α-β' 114-190. α-β 1137-1226 fusion protein did not have an interaction and 
should be further investigated to determine if the interaction is real.  
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pAcI-Tig + pBRα-β' 735-790 and pAcI-Tig + pBR α-β 450-530 had ~2-fold 
increase in β-galactosidase activity at 10 and 20μM IPTG compared to the negative 
controls. From this data, it was interpreted that the cI-Tig fusion protein had a significant 
interaction with the α- β' 735-790 and α-β 450-530 fusion protein at 10 and 20μM IPTG. 
Although not a huge interaction, this does indicate the interaction is real. Figure 28 
depicts mapping of the interactions with each target protein and pieces of the E. coli 
RNAP coreome. The center indicates the RNAP holoenzyme and each piece of RNAP. 
 
Figure 28: Crystal structure of the E. coli RNAP fragments that interacted with P. 
aeruginosa RNAP-interacting proteins. Image created with PyMol and Protein 
Data Bank structure 4MEY. Degen et al., Elife, 2014. 
 
α-Tig was chosen for further investigation. It was found to interact with β 450-
530. This was similar to what was found with E. coli Tig (performed by Padraig 
93 
 
Deighan). To further define which region of Tig interacted with RNAP, we studied how 
the individual domains interacted with RNAP β' 735-790 and β 450-530. This was 
performed to localize where RNAP interacts on Tig. No single Tig domain was found to 
interact with β’ 735-790 or β 450-530 of RNAP. One explanation could be that multiple 
Tig domains are required for the interaction with RNAP. Without all three domains 
present the protein may not fold in the correct 3-dimensional configuration to interact 
with RNAP. 
One strategy that could be used to define the region of Tig interaction with RNAP 
would be to make N-terminal or C-terminal deletion mutants. Progressively shorter Tig 
mutants could be made and tested to see when they fail to interact with RNAP β' 735-790 
and β 450-530. While ClpA, DppF, and Tig have not been specifically involved in 
virulence, this study is proof of concept that utilizing an E. coli RNAP coreome is 
possible to study P. aeruginosa RNAP-interacting proteins. The E. coli RNAP is an 
effective platform to study RNAP-interacting proteins in P. aeruginosa.    
As multidrug resistance P. aeruginosa becomes more prevalent, novel treatments 
are necessary to combat these infections. Currently, antibiotics target a small number of 
essential gene functions such as inhibition of cell wall synthesis, DNA replication, RNA 
transcription and protein synthesis. Virulence gene expression in vivo represents a 
potential target for antibiotic discovery. Utilizing a RNAP coreome to identify potential 
TFs in P. aeruginosa could result in the development of new antimicrobials that block 
virulence factors. Blocking the function of virulence factors (or their expression) could 
limit pathogen colonization, damage to host cells, and aid the host immune system in 
successful elimination of the pathogen. Furthermore, a RNAP coreome could be used to 
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discover essential RNAP interacting proteins.  Essential RNAP interacting proteins could 
also be targets for novel antimicrobials. Disrupting the function of such essential proteins 
could lead to the death of the pathogen.  
There is data supporting the concept that the E. coli RNAP coreome can be used 
to identify proteins associated with virulence that interact with RNAP. In Hung et al., 
2005 a high-throughput, phenotypic screen was used to identify a small molecule 
virstatin, that inhibits virulence regulation in Vibrio cholerae. By inhibiting the 
transcriptional regulator ToxT interaction with RNAP, virstatin prevents expression of 
two crucial virulence factors, cholera toxin and the toxin coregulated pilus. The bacterial 
two-hybrid assay was used to understand how virstatin worked. The experiments with 
virstatin demonstrate that, in principle, it might be possible to design drugs that disrupt 
interaction or function of this protein with RNAP. 
There are some limitations to utilizing a bacterial two-hybrid assay to study 
RNAP-interacting proteins with the E. coli RNAP coreome. pAcI-α 2-235 R45A of the 
coreome appears to be a sticky protein fragment. In over 60 target proteins tested with the 
coreome assay, α 2-235 R45A has been implicated in many non-specific interactions.  In 
this study, out of the 16 proteins, 5 screened proteins had an interaction with this piece of 
the RNAP coreome. These interactions were not investigated further because of the risk 
of exploring non-specific interactions.  
Other limitations of this system are that the fusion proteins are being induced with 
at most 20 μM of IPTG and therefore are not being overly expressed in most cases. The 
bacterial two-hybrid assay will not detect all TF-RNAP interactions. For example, weak 
interactions, DNA-dependent interactions, bridged interactions, or poorly expressed α 
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fusions may lead to a false negative outcome. Further research should be conducted on 
mutagenesis of the α-fusion proteins due to the possibility of bridged interactions. Also 
cloning the corresponding E. coli RNAP coreome pieces from P. aeruginosa and cloning 
it to the λcI protein would be another way to verify that the interaction is taking place in 
P. aeruginosa. 
While this work was able to demonstrate that an E. coli RNAP coreome could be 
utilized to study P. aeruginosa RNAP-interacting proteins, it is possible to optimize this 
system. To optimally study RNAP interacting proteins in P. aeruginosa, a P. aeruginosa 
coreome library could be constructed. The slight differences between P. aeruginosa and 
E. coli RNAP might result in some P. aeruginosa RNAP-protein interactions to be 
missed.  Screening P. aeruginosa proteins against a P. aeruginosa RNAP coreome would 
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ALIGNMENTS OF THE E. COLI RNAP COREOME TO THE CORESPONDING 






Figure 35A: pBLAST Alignment of Pseudomonas aeruginosa RNAP α 2-235 (top) to 
Escherichia coli RNAP α 2-235 (bottom).  
 
 
Figure 35B: pBLAST Alignment of Pseudomonas aeruginosa RNAP α 249-329 (top) to 






Figure 35C: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 1-151 (top) to 




Figure 35D: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 1-235 (top) to 
Escherichia coli RNAP β 1-235 (bottom).  
 
 
Figure 35E: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 25-104 (top) to 




Figure 35F: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 114-190 (top) to 
Escherichia coli RNAP β’ 114-190 (bottom).  
 
 
Figure 35G: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 140-235 (top) to 








Figure 35H: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 151-451 (top) to 




Figure 35I: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 193-230 (top) to 







Figure 35J: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 235-650 (top) to 





Figure 35K: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 249-328 (top) to 
Escherichia coli RNAP β’ 249-328 (bottom).  
 
 
Figure 35L: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 264-308 (top) to 





Figure 35M: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 370-416 (top) to 
Escherichia coli RNAP β’ 370-416 (bottom).  
 
 
Figure 35N: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 450-530 (top) to 




Figure 35O: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 516-573 (top) to 





Figure 35P: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 528-589 (top) to 





Figure 35Q: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 528-656 (top) to 




Figure 35R: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 576-634 (top) to 




Figure 35S: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 587-656 (top) to 








Figure 35T: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 648-701 (top) to 




Figure 35U: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 650-950 (top) to 




Figure 35V: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 665-798 (top) to 






Figure 35W: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 703-795 (top) to 
Escherichia coli RNAP β 703-795 (bottom).  
 
 
Figure 35X: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 735-790 (top) to 




Figure 35Y: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 820-882 (top) to 








Figure 35Z: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 829-930 (top) to 




Figure 35AA: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 831-1059 (top) 





Figure 35BB: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 930-1059 (top) 






Figure 35CC: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 944-1021 (top) 





Figure 35DD: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 944-1133 (top) 






Figure 35EE: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 950-1342 (top) 





Figure 35FF: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 1023-1128 




Figure 35GG: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 1137-1226 






Figure 35HH: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 1137-1243 




Figure 35II: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 1154-1212 (top) 
to Escherichia coli RNAP β’ 1154-1212 (bottom).  
 
 
Figure 35JJ: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 1261-1307 (top) 






Figure 35KK: pBLAST Alignment of Pseudomonas aeruginosa RNAP σ 94-448 (top) to 





Figure 35LL: pBLAST Alignment of Pseudomonas aeruginosa RNAP σ 528-613 (top) to 






















Figure 29: RNAP coreome screen displaying AtpD interactions with RNAP-α 2-
235 R45A. Diagram shows β-galactosidase transcription activation of a bacterial 
two-hybrid assay. This assay depicts interaction of an α-fusion of AtpD with cI-
fusion of the RNAP coreome. The dashed line indicates the average background 
level of β-galactosidase activity. pBRα and pACλcI plasmids directed the 
synthesis of fusion proteins under the control of IPTG-inducible promoters. The 
co-transformed FW102 OL2-62 reporter strain was grown in the presence of 20 
µM IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is 
expressed in Miller units indicated on the y-axis. The x-axis indicates the 






Figure 30: RNAP coreome screen displaying no interaction of ClpB. Diagram 
shows β-galactosidase transcription activation of a bacterial two-hybrid assay. 
This assay depicts no interaction of an α-fusion of ClpB with cI-fusion of the 
RNAP coreome. The dashed line indicates the average background level of β-
galactosidase activity. pBRα and pACλcI plasmids directed the synthesis of 
fusion proteins under the control of IPTG-inducible promoters. The co-
transformed FW102 OL2-62 reporter strain was grown in the presence of 20 µM 
IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is 
expressed in Miller units indicated on the y-axis. The x-axis indicates the 









Figure 31: RNAP coreome screen displaying GcvP interaction with RNAP-α 2-
235 R45A. Diagram shows β-galactosidase transcription activation of a bacterial 
two-hybrid assay. This assay depicts interaction of an α-fusion of GcvP with cI-
fusion of the RNAP coreome. The dashed line indicates the average background 
level of β-galactosidase activity. pBRα and pACλcI plasmids directed the 
synthesis of fusion proteins under the control of IPTG-inducible promoters. The 
co-transformed FW102 OL2-62 reporter strain was grown in the presence of 20 
µM IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is 
expressed in Miller units indicated on the y-axis. The x-axis indicates the 








Figure 32: RNAP coreome screen displaying no interaction with Lon. Diagram 
shows β-galactosidase transcription activation of a bacterial two-hybrid assay. 
This assay depicts no interaction of an α-fusion of Lon with cI-fusion of the 
RNAP coreome. The dashed line indicates the average background level of β-
galactosidase activity. pBRα and pACλcI plasmids directed the synthesis of 
fusion proteins under the control of IPTG-inducible promoters. The co-
transformed FW102 OL2-62 reporter strain was grown in the presence of 20 µM 
IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is 
expressed in Miller units indicated on the y-axis. The x-axis indicates the 










Figure 33: RNAP coreome screen displaying no interaction with PstB. Diagram 
shows β-galactosidase transcription activation of a bacterial two-hybrid assay. 
This assay depicts no interaction of an α-fusion of PstB with cI-fusion of the 
RNAP coreome. The dashed line indicates the average background level of β-
galactosidase activity. pBRα and pACλcI plasmids directed the synthesis of 
fusion proteins under the control of IPTG-inducible promoters. The co-
transformed FW102 OL2-62 reporter strain was grown in the presence of 20 µM 
IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is 
expressed in Miller units indicated on the y-axis. The x-axis indicates the 








Figure 34: RNAP coreome screen displaying no interaction with PyrG. Diagram 
shows β-galactosidase transcription activation of a bacterial two-hybrid assay. 
This assay depicts no interaction of an α-fusion of PyrG with cI-fusion of the 
RNAP coreome. The dashed line indicates the average background level of β-
galactosidase activity. pBRα and pACλcI plasmids directed the synthesis of 
fusion proteins under the control of IPTG-inducible promoters. The co-
transformed FW102 OL2-62 reporter strain was grown in the presence of 20 µM 
IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is 
expressed in Miller units indicated on the y-axis. The x-axis indicates the 
individual E. coli RNAP coreome fragments being expressed in the reporter 
strain. 
 
 
